{"content":"<li class=\"n-box-item date-title\" data-end=\"1515560399\" data-start=\"1515474000\" data-txt=\"Monday, December 23, 2019\">Tuesday, January  9, 2018</li><li class=\"n-box-item sa-box-item\" data-id=\"3322002\" data-ts=\"1515543115\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTK\" target=\"_blank\">FTK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3322002-flotek-names-new-chief-administrator-fires-up-new-citrus-oil-unit\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Flotek names new chief administrator, fires up new citrus oil unit</a></h4><ul>   <li>Flotek (NYSE:<a href='https://seekingalpha.com/symbol/FTK' title='Flotek Industries, Inc.'>FTK</a>) has named William York to the post of <a href=\"https://seekingalpha.com/pr/17042907-flotek-welcomes-new-chief-administrative-officer-expands-citrus-processing-capacity\" target=\"_blank\">chief administrative officer</a>.</li>    <li>He'll oversee human resources as well as IT, safety and administrative functions at the company, and report to CEO, President and Chairman John Chisholm.</li>    <li>York joins from Tudor Lewis, the executive search firm he founded; he has previous experience with TMP/Highland Partners and Bank of America.</li>    <li>The company also noted its new vacuum distillation unit is fully operational at its Winter Haven, Fla., facility.</li>    <li>That 20-drum custom unit will expand the company's citrus oil processing efficiency and capacity. It's got eight commercial distillation units dedicated to refining citrus oils.</li>    <li>Shares <font color='green'>rose 4.1%</font> during the regular session today.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3322002\" data-linked=\"Flotek names new chief administrator, fires up new citrus oil unit\" data-tweet=\"$FTK - Flotek names new chief administrator, fires up new citrus oil unit https://seekingalpha.com/news/3322002-flotek-names-new-chief-administrator-fires-up-new-citrus-oil-unit?source=tweet\" data-url=\"https://seekingalpha.com/news/3322002-flotek-names-new-chief-administrator-fires-up-new-citrus-oil-unit\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321998\" data-ts=\"1515537448\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321998-after-hours-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">After Hours Gainers / Losers</a></h4><ul>     <li><b>Top gainers:</b> <a href='https://seekingalpha.com/symbol/TSRI' title='TSR, Inc.'>TSRI</a> <font color='green'>+35.0%</font>. <a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='green'>+22.0%</font>. <a href='https://seekingalpha.com/symbol/AFSI' title='AmTrust Financial Services, Inc.'>AFSI</a> <font color='green'>+21.0%</font>. <a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a> <font color='green'>+9.0%</font>. <a href='https://seekingalpha.com/symbol/SHLM' title='A. Schulman, Inc.'>SHLM</a> <font color='green'>+5.2%</font>.</li><li><b>Top losers:</b> <a href='https://seekingalpha.com/symbol/ARRY' title='Array BioPharma Inc.'>ARRY</a> <font color='red'>-5.8%</font>. <a href='https://seekingalpha.com/symbol/FTFT' title='Future Fintech Group Inc'>FTFT</a> <font color='red'>-5.5%</font>. <a href='https://seekingalpha.com/symbol/XCRA' title='Xcerra Corporation'>XCRA</a> <font color='red'>-3.6%</font>. <a href='https://seekingalpha.com/symbol/CVI' title='CVR Energy, Inc.'>CVI</a> <font color='red'>-3.4%</font>. <a href='https://seekingalpha.com/symbol/INFN' title='Infinera Corporation'>INFN</a> <font color='red'>-3.0%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321998\" data-linked=\"After Hours Gainers / Losers\" data-tweet=\"$TSRI $TNDM $AFSI - After Hours Gainers / Losers https://seekingalpha.com/news/3321998-after-hours-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3321998-after-hours-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:37 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321997\" data-ts=\"1515536024\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GWRE\" target=\"_blank\">GWRE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321997-guidewire-announces-cfo-transition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Guidewire announces CFO transition</a></h4><ul><li>        Guidewire Software (NYSE:<a href='https://seekingalpha.com/symbol/GWRE' title='Guidewire Software, Inc.'>GWRE</a>) <a href=\"https://seekingalpha.com/pr/17042879-guidewire-software-announces-cfo-transition\" target=\"_blank\">announces</a> that CFO Richard Hart will transition into a role as Chief Strategy Officer on or around March 6.</li><li>               Curtis Smith will become the new CFO. Smith previously served in that role at Keynote Systems and Infusion Software.&nbsp;</li><li>               Guidewire shares are&nbsp;<font color='red'>down 0.3%</font>&nbsp;aftermarket.&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3321997\" data-linked=\"Guidewire announces CFO transition\" data-tweet=\"$GWRE - Guidewire announces CFO transition https://seekingalpha.com/news/3321997-guidewire-announces-cfo-transition?source=tweet\" data-url=\"https://seekingalpha.com/news/3321997-guidewire-announces-cfo-transition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:13 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321995\" data-ts=\"1515535492\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TSRI\" target=\"_blank\">TSRI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321995-tsr-reports-q2-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">TSR reports Q2 results</a></h4><ul><li>TSR (NASDAQ:<a href='https://seekingalpha.com/symbol/TSRI' title='TSR, Inc.'>TSRI</a>): Q2 EPS of $0.12</li><li>Revenue of $16.52M (+9.8% Y/Y)</li><li>Shares <font color='green'>+35%</font> AH.</li><li><a href='https://seekingalpha.com/pr/17042874-tsr-inc-reports-financial-results-second-quarter-ended-november-30-2017'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321995\" data-linked=\"TSR reports Q2 results\" data-tweet=\"$TSRI - TSR reports Q2 results https://seekingalpha.com/news/3321995-tsr-reports-q2-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3321995-tsr-reports-q2-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  5:04 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321989\" data-ts=\"1515534795\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NUAN\" target=\"_blank\">NUAN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321989-nuances-dragon-drive-powering-new-toyota-concept-car\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nuance&#39;s Dragon Drive powering new Toyota concept car</a></h4><ul>   <li>At CES, Nuance Communications (NASDAQ:<a href='https://seekingalpha.com/symbol/NUAN' title='Nuance Communications, Inc.'>NUAN</a>) is leaning on <a href=\"https://seekingalpha.com/pr/17042560-nuance-showcases-ai-powered-innovations-car-smart-home-future-ces-2018\" target=\"_blank\">new AI innovations</a> targeted not only at the home experience but at its burgeoning automotive platform.</li>    <li>The company's Dragon Drive connected-car platform is behind the auto assistant in <a href=\"https://seekingalpha.com/pr/17042559-nuance-s-dragon-drive-powers-automotive-assistant-toyota-concept-user-experience-concept\" target=\"_blank\">Toyota's Concept-i vehicle</a>, also on show in Las Vegas.</li>    <li>It offers features including \"voice-controlled restaurant and point of interest search, navigation, Q&amp;A, sports information, and integration with content providers like HERE and Yelp.\"</li>    <li>Nuance also says it's working with Toyota's \"emotion estimation engine\" to account for user's attention and emotional reaction to deliver more intelligent conversational interfaces.</li>    <li>Dragon Drive is in more than 200M cars on the road today, Nuance says.</li>    <li>The company's also showcasing enhanced capabilities for Loop, its AI-powered marketing platform for mobile operators to connect users with new services (and revenue streams).</li>    <li>Shares <font color='green'>rose 1.8%</font> during the session today. The company is said to be looking at strategic options for the auto business.</li>    <li>#CES18</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321989\" data-linked=\"Nuance&#39;s Dragon Drive powering new Toyota concept car\" data-tweet=\"$NUAN - Nuance&#39;s Dragon Drive powering new Toyota concept car https://seekingalpha.com/news/3321989-nuances-dragon-drive-powering-new-toyota-concept-car?source=tweet\" data-url=\"https://seekingalpha.com/news/3321989-nuances-dragon-drive-powering-new-toyota-concept-car\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321987\" data-ts=\"1515534611\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TNDM\" target=\"_blank\">TNDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321987-tandem-diabetes-care-sees-strong-2017-finish-q4-sales-up-over-35-shares-up-20-after-hours\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Tandem Diabetes Care sees strong 2017 finish, Q4 sales up over 35%; shares up 20% after hours</a></h4><ul><li>On a <a href=\"https://seekingalpha.com/pr/17042808-tandem-diabetes-care-announces-preliminary-2017-results-provides-2018-guidance\" target=\"_blank\">preliminary basis</a>, Tandem Diabetes Care (NASDAQ:<a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a>) expects Q4 2017 and full-year sales to be $39M - 40M (+37% from midpoint) and $106 - 107M (+26% from midpoint), respectively.</li><li>Pump shipments increased to ~7K (+58%) and 17.1K (+1%), respectively.</li><li>Preliminary 2018 guidance: Sales: $132M - 140M.</li><li>Final 2017 earnings will be released on Thursday, March 1 after the close.</li><li>Shares are up&nbsp;<font color='green'>20%</font>&nbsp;after hours on robust volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321987\" data-linked=\"Tandem Diabetes Care sees strong 2017 finish, Q4 sales up over 35%; shares up 20% after hours\" data-tweet=\"$TNDM - Tandem Diabetes Care sees strong 2017 finish, Q4 sales up over 35%; shares up 20% after hours https://seekingalpha.com/news/3321987-tandem-diabetes-care-sees-strong-2017-finish-q4-sales-up-over-35-shares-up-20-after-hours?source=tweet\" data-url=\"https://seekingalpha.com/news/3321987-tandem-diabetes-care-sees-strong-2017-finish-q4-sales-up-over-35-shares-up-20-after-hours\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:50 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>9&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321982\" data-ts=\"1515533462\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AFSI\" target=\"_blank\">AFSI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321982-amtrust-backers-make-privatization-proposal-shares-up-6_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AmTrust backers make privatization proposal; shares up 6.4%</a></h4><ul><li>A group made up of Stone Point Capital, Chairman and CEO Barry Zyskind, and the Karfunkel family are offering $12.25 per share in cash for the stock they don't currently hold.</li><li>The group currently owns or controls about 43% of AmTrust (NASDAQ:<a href='https://seekingalpha.com/symbol/AFSI' title='AmTrust Financial Services, Inc.'>AFSI</a>).</li><li>A special committee of the board is expected to be formed to study the bid.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17042835-stone-point-capital-partners-ceo-b-amtrust-b-financial-karfunkel-family-jointly-propose\" target=\"_blank\">Press Release</a></li><li>Shares&nbsp;<font color='green'>+6.4%</font>&nbsp;after hours to $10.80.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321982\" data-linked=\"AmTrust backers make privatization proposal; shares up 6.4%\" data-tweet=\"$AFSI - AmTrust backers make privatization proposal; shares up 6.4% https://seekingalpha.com/news/3321982-amtrust-backers-make-privatization-proposal-shares-up-6_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3321982-amtrust-backers-make-privatization-proposal-shares-up-6_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:31 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>63&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321977\" data-ts=\"1515532823\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VOXX\" target=\"_blank\">VOXX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321977-voxx-international-beats-0_23-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">VOXX International beats by $0.23, beats on revenue</a></h4><ul><li>VOXX International (NASDAQ:<a href='https://seekingalpha.com/symbol/VOXX' title='VOXX International Corp.'>VOXX</a>): Q3 EPS of $0.37 <font color='green'>beats by $0.23</font>.</li><li>Revenue of $156.56M (-0.5% Y/Y) <font color='green'>beats by $5.56M</font>.</li><li>Shares <font color='green'>+3%</font>.</li><li><a href='https://seekingalpha.com/pr/17042812-voxx-international-corporation-reports-fiscal-2018-third-quarter-financial-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321977\" data-linked=\"VOXX International beats by $0.23, beats on revenue\" data-tweet=\"$VOXX - VOXX International beats by $0.23, beats on revenue https://seekingalpha.com/news/3321977-voxx-international-beats-0_23-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3321977-voxx-international-beats-0_23-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:20 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>37&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321973\" data-ts=\"1515532569\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNX\" target=\"_blank\">SNX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321973-synnex-beats-0_11-beats-on-revenue\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synnex beats by $0.11, beats on revenue</a></h4><ul><li>Synnex (NYSE:<a href='https://seekingalpha.com/symbol/SNX' title='SYNNEX Corporation'>SNX</a>): Q4 EPS of $2.79 <font color='green'>beats by $0.11</font>.</li><li>Revenue of $5.31B (+36.5% Y/Y) <font color='green'>beats by $450M</font>.</li><li>Shares <font color='green'>+2.2%</font>.</li><li><a href='https://seekingalpha.com/pr/17042815-synnex-corporation-reports-fiscal-2017-fourth-quarter-full-year-results'>Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321973\" data-linked=\"Synnex beats by $0.11, beats on revenue\" data-tweet=\"$SNX - Synnex beats by $0.11, beats on revenue https://seekingalpha.com/news/3321973-synnex-beats-0_11-beats-on-revenue?source=tweet\" data-url=\"https://seekingalpha.com/news/3321973-synnex-beats-0_11-beats-on-revenue\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:16 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321971\" data-ts=\"1515532260\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JWN\" target=\"_blank\">JWN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321971-nordstrom-updates-guidance\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nordstrom updates guidance</a></h4><ul>     <li>Nordstrom (NYSE:<a href='https://seekingalpha.com/symbol/JWN' title='Nordstrom Inc.'>JWN</a>) reports holiday sales increased 2.5%.</li>     <li>Comparable sales were up 1.2% for the crucial two-month period.</li>     <li>Based on holiday results, Nordstrom says it sees FY17 sales growth of 4.2% and EPS of $2.90 to $2.95 vs. $2.99 consensus and $2.85 to $2.95 prior.</li>     <li>The company is scheduled to report full Q4 results on March 1.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/17042781-nordstrom-reports-november-december-combined-sales\" target=\"_blank\">Press Release</a></li>      </ul><div class=\"tiny-share-widget\" data-id=\"3321971\" data-linked=\"Nordstrom updates guidance\" data-tweet=\"$JWN - Nordstrom updates guidance https://seekingalpha.com/news/3321971-nordstrom-updates-guidance?source=tweet\" data-url=\"https://seekingalpha.com/news/3321971-nordstrom-updates-guidance\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:11 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321967\" data-ts=\"1515532028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTN\" target=\"_blank\">MTN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321967-vail-rallies-on-hopes-for-big-mlk-weekend\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Vail rallies on hopes for big MLK weekend</a></h4><ul> <li>Vail Resorts (NYSE:<a href='https://seekingalpha.com/symbol/MTN' title='Vail Resorts, Inc.'>MTN</a>) closed with a <font color='green'>3.71% gain</font> on strong volume after a weather forecast for \"significant\" mountain snow stirred up optimism that MLK weekend resort traffic could be high.</li> <li>Snow accumualtions of 8 to 16 inches are forecast by the National Weather Service.</li> <li>Reports on January traffic to date at Vail have been disappointing.</li><li>Sources: Bloomberg, National Weather Service</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321967\" data-linked=\"Vail rallies on hopes for big MLK weekend\" data-tweet=\"$MTN - Vail rallies on hopes for big MLK weekend https://seekingalpha.com/news/3321967-vail-rallies-on-hopes-for-big-mlk-weekend?source=tweet\" data-url=\"https://seekingalpha.com/news/3321967-vail-rallies-on-hopes-for-big-mlk-weekend\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  4:07 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321961\" data-ts=\"1515531203\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AKAM\" target=\"_blank\">AKAM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321961-bloomberg-akamai-pursuing-strategic-alternatives-sale\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Akamai pursuing strategic alternatives, sale</a></h4><ul><li>        Akamai (NASDAQ:<a href='https://seekingalpha.com/symbol/AKAM' title='Akamai Technologies, Inc.'>AKAM</a>) is working with Morgan Stanley to explore strategic alternatives including a potential sale, according to <a href=\"https://www.bloomberg.com/news/articles/2018-01-09/akamai-is-working-with-morgan-stanley-on-strategic-review\" target=\"_blank\">Bloomberg sources</a>.</li><li>                  The exploration comes after pressure from activist investor Elliott Management. &nbsp;   </li><li>               Akamai shares are&nbsp;<font color='green'>up 2.1%</font>.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3318724-akamai-plus-10_7-percent-active-stake-reveal\" target=\"_blank\">Akamai +10.7% after active stake reveal</a> (Dec. 15, 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3319231-craig-hallum-upgrades-akamai-activist-investor\" target=\"_blank\">Craig-Hallum upgrades Akamai on activist investor</a> (Dec. 19, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321961\" data-linked=\"Bloomberg: Akamai pursuing strategic alternatives, sale\" data-tweet=\"$AKAM - Bloomberg: Akamai pursuing strategic alternatives, sale https://seekingalpha.com/news/3321961-bloomberg-akamai-pursuing-strategic-alternatives-sale?source=tweet\" data-url=\"https://seekingalpha.com/news/3321961-bloomberg-akamai-pursuing-strategic-alternatives-sale\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:53 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321959\" data-ts=\"1515530922\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DE\" target=\"_blank\">DE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321959-deere-up-another-3-after-analyst-meeting\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Deere up another 3% after analyst meeting</a></h4><ul><li>Barclays' Adam Seiden was impressed, saying the stock continues to have room to run after&nbsp;<font color='green'>a near-60% advance</font>&nbsp;over the past year. The Wirtgen Group purchase last summer should allow construction margins to grow by 300-350 basis points in 2019.</li><li>Management was optimistic, says Blair's Lawrence De Maria, thanks to the implementation of structural cost savings and a flat to improved outlook for most markets this year.</li><li>Deere (<a href='https://seekingalpha.com/symbol/DE' title='Deere & Company'>DE</a> <font color='green'>+2.9%</font>), he says, believes there's a new normal of $3.50 corn and $9.50 beans.</li><li>Source: Bloomberg's Esha Dey</li></ul><div class=\"tiny-share-widget\" data-id=\"3321959\" data-linked=\"Deere up another 3% after analyst meeting\" data-tweet=\"$DE - Deere up another 3% after analyst meeting https://seekingalpha.com/news/3321959-deere-up-another-3-after-analyst-meeting?source=tweet\" data-url=\"https://seekingalpha.com/news/3321959-deere-up-another-3-after-analyst-meeting\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321958\" data-ts=\"1515530906\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BHC\" target=\"_blank\">BHC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321958-valeant-presentation-jpm18-set-for-tomorrow-1-30-et-shares-up-3\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Valeant presentation at JPM18 set for tomorrow at 1:30 ET; shares up 3%</a></h4><ul><li>Valeant Pharmaceuticals (VRX <font color='green'>+3.2%</font>) chief Joseph Papa will deliver a <a href=\"http://ir.valeant.com/events-and-presentations/2018\" target=\"_blank\">corporate overview</a> at JPM18 tomorrow, January 10, at 1:30 pm ET (10:30 am PT). Key points:</li><li>Company turnaround and reignition of growth to be driven by resolving legacy issues, de-risking the balance sheet, investing in core franchises with attractive growth and launching new products with meaningful opportunities.</li><li>Dermatology turnaround to be driven by new products. FDA action date for topical psoriasis med DUOBRII (IDP-118) June 18. Derm salesforce to be increased 25%, focus on psoriasis. U.S. marketing applications for ALTRENO (IDP-121) for acne (October 2017) and JEMDEL (IDP-122) for psoriasis (December 2017) filed.</li><li>February 13 FDA action date for PLENVU (NER1006) bowel prep marketing application.</li><li>Cash flow from operations was $1.712B for first three quarters of 2017. Total debt reduced by more than $6.5B since Q1 2016.</li><li>#JPM18</li></ul><div class=\"tiny-share-widget\" data-id=\"3321958\" data-linked=\"Valeant presentation at JPM18 set for tomorrow at 1:30 ET; shares up 3%\" data-tweet=\"$BHC - Valeant presentation at JPM18 set for tomorrow at 1:30 ET; shares up 3% https://seekingalpha.com/news/3321958-valeant-presentation-jpm18-set-for-tomorrow-1-30-et-shares-up-3?source=tweet\" data-url=\"https://seekingalpha.com/news/3321958-valeant-presentation-jpm18-set-for-tomorrow-1-30-et-shares-up-3\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  3:48 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321952\" data-ts=\"1515527750\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321952-technology-top-gainers-losers-of-2-55-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Technology - Top Gainers / Losers as of 2:55 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a> <font color='green'>+16%</font>. <a href='https://seekingalpha.com/symbol/GSUM' title='Gridsum Holding'>GSUM</a> <font color='green'>+14%</font>. <a href='https://seekingalpha.com/symbol/CAMT' title='Camtek Ltd.'>CAMT</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/ATUS' title='Altice USA'>ATUS</a> <font color='green'>+10%</font>. <a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='green'>+11%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-40%</font>. <a href='https://seekingalpha.com/symbol/SIFY' title='Sify Technologies Limited'>SIFY</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/TEUM' title='Pareteum Corporation'>TEUM</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/DPW' title='DPW Holdings, Inc.'>DPW</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/AYI' title='Acuity Brands, Inc. &#40;Holding Company&#41;'>AYI</a> <font color='red'>-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321952\" data-linked=\"Technology - Top Gainers / Losers as of 2:55 pm\" data-tweet=\"$XNET $GSUM $CAMT - Technology - Top Gainers / Losers as of 2:55 pm https://seekingalpha.com/news/3321952-technology-top-gainers-losers-of-2-55-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321952-technology-top-gainers-losers-of-2-55-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:55 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321944\" data-ts=\"1515524518\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321944-energy-materials-top-gainers-losers-of-2-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Energy/Materials - Top Gainers / Losers as of 2:00 pm</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/CGG-OLD' title='CGG'>CGG-OLD</a> <font color='green'>+24%</font>. <a href='https://seekingalpha.com/symbol/USAU' title='U.S. Gold Corp.'>USAU</a> <font color='green'>+12%</font>. <a href='https://seekingalpha.com/symbol/SN' title='Sanchez Energy Corporation'>SN</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/PES' title='Pioneer Energy Services'>PES</a> <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/BPT' title='BP Prudhoe Bay Royalty Trust'>BPT</a> <font color='green'>+7%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/AKS' title='AK Steel Holding Corp'>AKS</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/SSRM' title='SSR Mining Inc'>SSRM</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/GST' title='Gastar Exploration Inc.'>GST</a> <font color='red'>-8%</font>. <a href='https://seekingalpha.com/symbol/ACH' title='Aluminum Corporation of China Ltd'>ACH</a> <font color='red'>-7%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321944\" data-linked=\"Energy/Materials - Top Gainers / Losers as of 2:00 pm\" data-tweet=\"$CGG-OLD $USAU $SNEC - Energy/Materials - Top Gainers / Losers as of 2:00 pm https://seekingalpha.com/news/3321944-energy-materials-top-gainers-losers-of-2-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321944-energy-materials-top-gainers-losers-of-2-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  2:01 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321941\" data-ts=\"1515522889\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FOGO\" target=\"_blank\">FOGO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321941-credit-suisse-updates-on-fogo-de-chao\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Credit Suisse updates on Fogo De Chao</a></h4><ul> <li>Credit Suisse posts an update on Neutral-rated Fogo De Chao (<a href='https://seekingalpha.com/symbol/FOGO' title='Fogo de Chao'>FOGO</a> <font color='green'>+1.5%</font>) after meeting with management at ICR.</li> <li>\"Mgmt. cited initiatives such as day part expansion, new bar menus, remodels and a more favorable holiday calendar for the improved sales,\" reports the analyst team.</li> <li>\"We came away from the meeting more optimistic that FOGO can deliver EBITDA and EPS growth in 2018, with the latter helped by tax reform (mgmt. estimates ~21-25% tax rate post-reform).\"</li> <li>Credit Suisse raises its price target to $14 from $11.50.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321718-icr-fogo-de-chao-sees-growing-u-s-store-base-10-percent\" target=\"_blank\">ICR: Fogo de Chao sees growing U.S. store base 10%</a> (Jan. 8)</li><li><a href=\"https://seekingalpha.com/news/search?query=%23ICR18\" target=\"_blank\">#ICR18</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3321941\" data-linked=\"Credit Suisse updates on Fogo De Chao\" data-tweet=\"$FOGO - Credit Suisse updates on Fogo De Chao https://seekingalpha.com/news/3321941-credit-suisse-updates-on-fogo-de-chao?source=tweet\" data-url=\"https://seekingalpha.com/news/3321941-credit-suisse-updates-on-fogo-de-chao\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:34 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321939\" data-ts=\"1515521718\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/WTW\" target=\"_blank\">WTW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321939-oprah-squeeze-weight-watchers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oprah squeeze at Weight Watchers</a></h4><ul> <li>Talk of an Oprah Winfrey run in the 2020 Presidential election has done a <a href=\"https://www.barrons.com/articles/weight-watchers-bears-get-walloped-in-the-wallet-1515508728\" target=\"_blank\">number</a> on shorts hoping for weakness in shares of Weight Watchers (<a href='https://seekingalpha.com/symbol/WTW' title='Weight Watchers International, Inc.'>WTW</a> <font color='green'>+6.9%</font>), observes S3 Partners analyst Ihor Dusaniwky.</li> <li>\"WTW short interest peaked in mid-August 2017 at $443 million and after hitting a yearly low of $208 million in September short sellers began to gradually accumulate short exposure. Short interest has remained relatively stable over the last several months, trading at a range between $300 million and $400 million,\" writes Dusaniwsky</li> <li>Shares of WTW are up around 20% over the last two days and carved out a new 52-week high of $57.13 earlier.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321640-weight-watchers-plus-10-percent-oprah-jolt\" target=\"_blank\">Weight Watchers +10% after Oprah jolt</a> (Jan. 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321939\" data-linked=\"Oprah squeeze at Weight Watchers\" data-tweet=\"$WTW $WW - Oprah squeeze at Weight Watchers https://seekingalpha.com/news/3321939-oprah-squeeze-weight-watchers?source=tweet\" data-url=\"https://seekingalpha.com/news/3321939-oprah-squeeze-weight-watchers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:15 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321937\" data-ts=\"1515521576\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/NKTR\" target=\"_blank\">NKTR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321937-nektar-up-9-ahead-of-jpm18-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Nektar up 9% ahead of JPM18 presentation</a></h4><ul><li>Nektar Therapeutics (<a href='https://seekingalpha.com/symbol/NKTR' title='Nektar Therapeutics'>NKTR</a> <font color='green'>+8.5%</font>) heads north, albeit on low volume, ahead of a <a href=\"https://seekingalpha.com/pr/17036673-nektar-therapeutics-president-ceo-howard-robin-present-36th-annual-j-p-morgan-healthcare\" target=\"_blank\">presentation </a>this morning at 11:00 am PT by CEO Howard Robin at JPM18.</li><li>Shares have rallied almost 180% since early November when the company announced positive data on NKTR-214 and NKTR-358.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3311415-nektar-therapeutics-25-percent-premarket-encouraging-preclinical-data-immune-system\" target=\"_blank\">Nektar Therapeutics up 25% premarket on encouraging preclinical data on immune system stimulator NKTR-214</a> (Nov. 13, 2017)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3309129-preclinical-data-show-encouraging-action-nektars-immune-system-balancer-nktrminus-358-shares\" target=\"_blank\">Preclinical data show encouraging action for Nektar's immune system balancer NKTR-358; shares ahead 5%</a> (Nov. 7, 2017)</li><li>#JPM18</li></ul><div class=\"tiny-share-widget\" data-id=\"3321937\" data-linked=\"Nektar up 9% ahead of JPM18 presentation\" data-tweet=\"$NKTR - Nektar up 9% ahead of JPM18 presentation https://seekingalpha.com/news/3321937-nektar-up-9-ahead-of-jpm18-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3321937-nektar-up-9-ahead-of-jpm18-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:12 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321938\" data-ts=\"1515521372\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BKS\" target=\"_blank\">BKS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321938-barnes-noble-drifts-to-20-year-low\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Barnes &amp; Noble drifts to 20-year low</a></h4><ul> <li>Barnes &amp; Noble (<a href='https://seekingalpha.com/symbol/BKS' title='Barnes & Noble Inc'>BKS</a> <font color='red'>-6.8%</font>) fell to more than a twenty-year low of $4.95 earlier today before pushing back over $5.00.</li> <li>Sentiment on the retailer continues to be very weak since its disappointing update on holiday sales.</li> <li>On the bright side, the enterprise value on B&amp;N is said to be <a href=\"https://www.barrons.com/articles/barnes-noble-christmas-never-came-1515171251\" target=\"_blank\">attractive</a> now to a private equity buyer.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321436-painful-drop-barnes-and-noble\" target=\"_blank\">Painful drop for Barnes &amp; Noble</a> (Jan. 5)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321615-barnes-and-noble-misses-early-rush-fire-fury\" target=\"_blank\">Barnes &amp; Noble misses out on early rush for 'Fire and Fury'</a> (Jan. 8)</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321938\" data-linked=\"Barnes &amp; Noble drifts to 20-year low\" data-tweet=\"$BKS - Barnes &amp; Noble drifts to 20-year low https://seekingalpha.com/news/3321938-barnes-noble-drifts-to-20-year-low?source=tweet\" data-url=\"https://seekingalpha.com/news/3321938-barnes-noble-drifts-to-20-year-low\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:09 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321936\" data-ts=\"1515521195\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RPT\" target=\"_blank\">RPT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321936-another-tough-year-ahead-for-strip-malls\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Another tough year ahead for strip malls</a></h4><ul><li>\"It's difficult to get bullish,\" on strip malls, says Boenning &amp; Scattergood's Floris van Dijkum.</li><li>He sees strip mall players' earnings sliding 2% this year, and has Underperform ratings on Ramco-Gershenson Trust (<a href='https://seekingalpha.com/symbol/RPT' title='RPT Realty'>RPT</a> <font color='red'>-3%</font>), DDR (DDR <font color='red'>-2.4%</font>), and Cedar Realty (<a href='https://seekingalpha.com/symbol/CDR' title='Cedar Realty Trust, Inc.'>CDR</a> <font color='red'>-2.5%</font>).</li><li>Van Dijkum expects better performance from malls and hotels.</li><li>Source: Bloomberg</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321935-reits-roughed-rates-break-utilities\" target=\"_blank\">REITs roughed-up as rates break out; utilities too</a> (Jan. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321936\" data-linked=\"Another tough year ahead for strip malls\" data-tweet=\"$RPT $RPT $SITC - Another tough year ahead for strip malls https://seekingalpha.com/news/3321936-another-tough-year-ahead-for-strip-malls?source=tweet\" data-url=\"https://seekingalpha.com/news/3321936-another-tough-year-ahead-for-strip-malls\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:06 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321935\" data-ts=\"1515521002\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/O\" target=\"_blank\">O</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321935-reits-roughed-up-rates-break-out-utilities-too\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">REITs roughed-up as rates break out; utilities too</a></h4><ul><li>The bear market in bonds was confirmed today,&nbsp; <a href=\"https://seekingalpha.com/news/3321931-gross-bond-bear-market-confirmed-today\" target=\"_blank\">says Bill Gross</a>, reacting to new cycle highs in 5- and 10-year Treasury yields.</li><li>Income favorites like REITs (<a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a> <font color='red'>-0.8%</font>) and utilities (<a href='https://seekingalpha.com/symbol/XLU' title='Utilities Select Sector SPDR ETF'>XLU</a> <font color='red'>-0.9%</font>) are selling off thanks to the boosted competition. The major averages, in the meantime, are all in the green.</li><li>Realty Income (<a href='https://seekingalpha.com/symbol/O' title='Realty Income Corporation'>O</a> <font color='red'>-0.9%</font>), Omega Healthcare (<a href='https://seekingalpha.com/symbol/OHI' title='Omega Healthcare Investors, Inc'>OHI</a> <font color='red'>-1.6%</font>), HCP (<a href='https://seekingalpha.com/symbol/HCP' title='HCP, Inc.'>HCP</a> <font color='red'>-1.3%</font>), Vereit (<a href='https://seekingalpha.com/symbol/VER' title='VEREIT Inc.'>VER</a> <font color='red'>-0.6%</font>), Equity Residential (<a href='https://seekingalpha.com/symbol/EQR' title='Equity Residential'>EQR</a> <font color='red'>-1.4%</font>), Simon Property (<a href='https://seekingalpha.com/symbol/SPG' title='Simon Property Group, Inc.'>SPG</a> <font color='red'>-1.6%</font>), Kimco (<a href='https://seekingalpha.com/symbol/KIM' title='Kimco Realty Corporation'>KIM</a> <font color='red'>-2.7%</font>), Extra Space Storage (<a href='https://seekingalpha.com/symbol/EXR' title='Extra Space Storage, Inc.'>EXR</a> <font color='red'>-1.2%</font>), Boston Properties (<a href='https://seekingalpha.com/symbol/BXP' title='Boston Properties, Inc.'>BXP</a> <font color='red'>-1%</font>), Pebblebrook Hotel (<a href='https://seekingalpha.com/symbol/PEB' title='Pebblebrook Hotel Trust'>PEB</a> <font color='red'>-1.3%</font>), Select Income REIT (<a href='https://seekingalpha.com/symbol/SIR' title='Select Income REIT'>SIR</a> <font color='red'>-1%</font>)</li><li>ETFs: <a href='https://seekingalpha.com/symbol/VNQ' title='Vanguard Real Estate ETF'>VNQ</a>, <a href='https://seekingalpha.com/symbol/IYR' title='iShares U.S. Real Estate ETF'>IYR</a>, <a href='https://seekingalpha.com/symbol/XLU' title='Utilities Select Sector SPDR ETF'>XLU</a>, <a href='https://seekingalpha.com/symbol/UTG' title='Reaves Utility Income Fund'>UTG</a>, <a href='https://seekingalpha.com/symbol/RQI' title='Cohen&Steers Quality Income Realty Fund'>RQI</a>, <a href='https://seekingalpha.com/symbol/VPU' title='Vanguard Utilities ETF'>VPU</a>, <a href='https://seekingalpha.com/symbol/SCHH' title='Schwab U.S. REIT ETF'>SCHH</a>, <a href='https://seekingalpha.com/symbol/RNP' title='Cohen&Steers REIT&Preferred Income Fund'>RNP</a>, <a href='https://seekingalpha.com/symbol/RFI' title='Cohen&Steers Total Return Realty Fund'>RFI</a>, <a href='https://seekingalpha.com/symbol/GUT' title='Gabelli Utility Trust'>GUT</a>, <a href='https://seekingalpha.com/symbol/IDU' title='iShares U.S. Utilities ETF'>IDU</a>, <a href='https://seekingalpha.com/symbol/KBWY' title='Invesco KBW Premium Yield Equity REIT Portfolio ETF'>KBWY</a>, <a href='https://seekingalpha.com/symbol/DRN' title='Direxion Daily Real Estate Bull 3x Shares ETF'>DRN</a>, <a href='https://seekingalpha.com/symbol/BUI' title='BlackRock Utility&Infrastructure Trust'>BUI</a>, <a href='https://seekingalpha.com/symbol/NRO' title='Neuberger Berman Real Estate Securities Income Fund'>NRO</a>, <a href='https://seekingalpha.com/symbol/URE' title='ProShares Ultra Real Estate ETF'>URE</a>, <a href='https://seekingalpha.com/symbol/ICF' title='iShares Cohen & Steers REIT ETF'>ICF</a>, <a href='https://seekingalpha.com/symbol/XLRE' title='Real Estate Select Sector SPDR ETF'>XLRE</a>, <a href='https://seekingalpha.com/symbol/JRS' title='Nuveen Real Estate Income Fund'>JRS</a>, <a href='https://seekingalpha.com/symbol/RWR' title='SPDR Dow Jones REIT ETF'>RWR</a>, <a href='https://seekingalpha.com/symbol/SRS' title='ProShares UltraShort Real Estate ETF'>SRS</a>, <a href='https://seekingalpha.com/symbol/FUTY' title='Fidelity MSCI Utilities Index ETF'>FUTY</a>, <a href='https://seekingalpha.com/symbol/FREL' title='Fidelity MSCI Real Estate Index ETF'>FREL</a>, <a href='https://seekingalpha.com/symbol/DRA' title='Diversified Real Asset Income Fund'>DRA</a>, <a href='https://seekingalpha.com/symbol/DRV' title='Direxion Daily Real Estate Bear 3x Shares ETF'>DRV</a>, <a href='https://seekingalpha.com/symbol/RIF' title='RMR Real Estate Income Fund'>RIF</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321935\" data-linked=\"REITs roughed-up as rates break out; utilities too\" data-tweet=\"$O $IYR $XLU - REITs roughed-up as rates break out; utilities too https://seekingalpha.com/news/3321935-reits-roughed-up-rates-break-out-utilities-too?source=tweet\" data-url=\"https://seekingalpha.com/news/3321935-reits-roughed-up-rates-break-out-utilities-too\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:03 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>135&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321933\" data-ts=\"1515520802\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321933-financials-top-5-gainers-losers-of-1-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Financials - Top 5 Gainers / Losers as of 1:00 PM</a></h4><ul><li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/MMAC' title='MMA Capital Holdings, Inc.'>MMAC</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/JP' title='Jupai Holdings'>JP</a> <font color='green'>+10%</font>.<a href='https://seekingalpha.com/symbol/LMFA' title='LM Funding America, Inc.'>LMFA</a> <font color='green'>+7%</font>. <a href='https://seekingalpha.com/symbol/UCBI' title='United Community Banks, Inc.'>UCBI</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/CARV' title='Carver Bancorp, Inc.'>CARV</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/SGLB' title='Sigma Labs, Inc.'>SGLB</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/HGSH' title='China HGS Real Estate, Inc.'>HGSH</a> <font color='red'>-8%</font>. OAKS <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/BRG' title='Bluerock Residential Growth REIT, Inc.'>BRG</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321933\" data-linked=\"Financials - Top 5 Gainers / Losers as of 1:00 PM\" data-tweet=\"$MMAC $JP $LMFA - Financials - Top 5 Gainers / Losers as of 1:00 PM https://seekingalpha.com/news/3321933-financials-top-5-gainers-losers-of-1-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321933-financials-top-5-gainers-losers-of-1-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  1:00 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321932\" data-ts=\"1515520303\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IBM\" target=\"_blank\">IBM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321932-ibm-tops-list-of-u-s-patents-for-25th-year\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">IBM tops list of U.S. patents for 25th year</a></h4><ul><li>IBM (NYSE:<a href='https://seekingalpha.com/symbol/IBM' title='International Business Machines Corporation'>IBM</a>) received a <a href=\"https://seekingalpha.com/pr/17041291-ibm-breaks-records-top-u-s-patent-list-25th-consecutive-year\" target=\"_blank\">record 9,043 patents</a> in 2017, which made the company number one in U.S. patent assignments for the 25th year.</li><li>Analytics firm IFI Claims <a href=\"https://techcrunch.com/2018/01/09/ibm-led-on-patents-in-2017-facebook-broke-into-top-50-for-the-first-time/?ncid=rss&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+Techcrunch+%28TechCrunch%29\" target=\"_blank\">released</a> its annual list of rankings and Samsung came second with 3,300 fewer patents than IBM.</li><li>Other members of the top 10: Canon, Intel, LG Electronics, Qualcomm, Google, Microsoft, and Taiwan Semiconductor Manufacturing Company.</li><li>IBM&rsquo;s patents included 1,900 for cloud-related tech, 1,400 for AI, and 1,200 for cybersecurity.</li><li>IBM has now surpassed 100,000 U.S. patents issued from 1993 to 2017.</li><li>IBM shares are&nbsp;<font color='green'>up 0.5%</font>.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321381-axios-aspen-institute-launching-cybersecurity-initiative-ibm-politicians-academics\" target=\"_blank\">Axios: Aspen Institute launching cybersecurity initiative with IBM, politicians, academics</a> (Jan. 5)</li><li>Correction: Post updated to correct the number of AI patents.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321932\" data-linked=\"IBM tops list of U.S. patents for 25th year\" data-tweet=\"$IBM - IBM tops list of U.S. patents for 25th year https://seekingalpha.com/news/3321932-ibm-tops-list-of-u-s-patents-for-25th-year?source=tweet\" data-url=\"https://seekingalpha.com/news/3321932-ibm-tops-list-of-u-s-patents-for-25th-year\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>22&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321930\" data-ts=\"1515520282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DRRX\" target=\"_blank\">DRRX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321930-durect-up-11-on-pain-therapeutics-remoxy-stoked-rally\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Durect up 11% on Pain Therapeutics&#39; Remoxy-stoked rally</a></h4><ul><li>DURECT (<a href='https://seekingalpha.com/symbol/DRRX' title='Durect Corporation'>DRRX</a> <font color='green'>+10.8%</font>) jumps on triple normal volume in conjunction with the rally in Pain Therapeutics (<a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+144.5%</font>) after the latter reported positive results from a nasal abuse potential study for REMOXY ER (extended-release oxycodone capsules CII) which will support the resubmission of its U.S. marketing application.</li><li>REMOXY incorporates DURECT's <a href=\"http://www.durect.com/science-technologies/oradur-oral-delivery-system/\" target=\"_blank\">ORADUR </a>abuse-deterrent technology, <a href=\"http://investors.durect.com/phoenix.zhtml?c=121590&amp;p=irol-newsArticle_Print&amp;ID=1510717\" target=\"_blank\">licensed </a>to Pain in December 2002. Under the terms of the agreement, DURECT is eligible to receive royalties of 6.0 - 11.5% on net sales in addition to a mark-up on certain excipients used in manufacturing.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321852-pain-therapeutics-abuse-deterrent-remoxy-successful-nasal-abuse-potential-study-shares-ahead\" target=\"_blank\">Pain Therapeutic's abuse-deterrent Remoxy successful in nasal abuse potential study; shares ahead 12% premarket</a> (Jan. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321930\" data-linked=\"Durect up 11% on Pain Therapeutics&#39; Remoxy-stoked rally\" data-tweet=\"$DRRX $DRRX $SAVA - Durect up 11% on Pain Therapeutics&#39; Remoxy-stoked rally https://seekingalpha.com/news/3321930-durect-up-11-on-pain-therapeutics-remoxy-stoked-rally?source=tweet\" data-url=\"https://seekingalpha.com/news/3321930-durect-up-11-on-pain-therapeutics-remoxy-stoked-rally\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:51 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321927\" data-ts=\"1515519729\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321927-midday-gainers-losers\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Midday Gainers / Losers</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+143%</font>. <a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a> <font color='green'>+39%</font>. <a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a> <font color='green'>+31%</font>. <a href='https://seekingalpha.com/symbol/KEN' title='Kenon Holdings Ltd'>KEN</a> <font color='green'>+27%</font>. <a href='https://seekingalpha.com/symbol/CGG-OLD' title='CGG'>CGG-OLD</a> <font color='green'>+24%</font>. ITUS <font color='green'>+21%</font>. <a href='https://seekingalpha.com/symbol/ALDR' title='Alder Biopharmaceuticals Inc.'>ALDR</a> <font color='green'>+20%</font>. <a href='https://seekingalpha.com/symbol/MMAC' title='MMA Capital Holdings, Inc.'>MMAC</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ABAX' title='ABAXIS, Inc.'>ABAX</a> <font color='green'>+17%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/AMMA-OLD' title='Alliance MMA'>AMMA-OLD</a> <font color='red'>-43%</font>. <a href='https://seekingalpha.com/symbol/ARDM' title='Aradigm Corp.'>OTC:ARDM</a> <font color='red'>-37%</font>. <a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a> <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-28%</font>. <a href='https://seekingalpha.com/symbol/APHB' title='AmpliPhi Biosciences Corp.'>APHB</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/DELT' title='Delta Technology Holdings Limited'>DELT</a> <font color='red'>-19%</font>. <a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a> <font color='red'>-17%</font>. <a href='https://seekingalpha.com/symbol/QTNT' title='Quotient Limited'>QTNT</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a> <font color='red'>-16%</font>. <a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a> <font color='red'>-15%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321927\" data-linked=\"Midday Gainers / Losers\" data-tweet=\"$SAVA $DFFN $KODK - Midday Gainers / Losers https://seekingalpha.com/news/3321927-midday-gainers-losers?source=tweet\" data-url=\"https://seekingalpha.com/news/3321927-midday-gainers-losers\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:42 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321925\" data-ts=\"1515518727\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNE\" target=\"_blank\">SNE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321925-sony-unveils-google-assistant-enabled-headphones-new-and-old\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Sony unveils Google Assistant-enabled headphones, new and old</a></h4><ul><li>        Sony (NYSE:<a href='https://seekingalpha.com/symbol/SNE' title='Sony Corporation'>SNE</a>) announces two new headphone styles that come with Google&nbsp;(<a href='https://seekingalpha.com/symbol/GOOG' title='Alphabet, Inc. Cl C'>GOOG</a>, <a href='https://seekingalpha.com/symbol/GOOGL' title='Alphabet, Inc. Cl A'>GOOGL</a>)&nbsp;Assistant capabilities. The company also plans to add Assistant to some older headphones retroactively.</li><li>               Flagship WF-SP700N will sell for $179.99. The Bluetooth headphones have a sleek, pill-shaped design and feature noise cancelation, Ambient Mode, and up to three hours of play on one charge.&nbsp;</li><li>               The bulkier WI-SP600N headphones will sell for $149.99. The model has noise cancellation features and six hours of battery life via USB cord.&nbsp;</li><li>               Software updates will bring Assistant to five older models, including the predecessors to the newly announced headphones. &nbsp;&nbsp;</li><li>                  Sony shares are&nbsp;<font color='green'>up 1.1%</font>.&nbsp;&nbsp;&nbsp; </li><li>           #CES18&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3321477-google-releases-home-sales-info-ces-assistant-focus\" target=\"_blank\">Google releases Home sales info, CES Assistant focus</a> (Jan. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321925\" data-linked=\"Sony unveils Google Assistant-enabled headphones, new and old\" data-tweet=\"$SNE $SNE $GOOG - Sony unveils Google Assistant-enabled headphones, new and old https://seekingalpha.com/news/3321925-sony-unveils-google-assistant-enabled-headphones-new-and-old?source=tweet\" data-url=\"https://seekingalpha.com/news/3321925-sony-unveils-google-assistant-enabled-headphones-new-and-old\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:25 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321923\" data-ts=\"1515518475\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KODK\" target=\"_blank\">KODK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321923-old-school-kodakplus-67-on-blockchain-move\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Old school Kodak +67% on blockchain move</a></h4><ul> <li>Eastman Kodak (NYSE:<a href='https://seekingalpha.com/symbol/KODK' title='Eastman Kodak Co.'>KODK</a>)&nbsp;<font color='green'>spikes 67%</font>&nbsp;after announcing a crypto move.</li><li>Kodak and WENN Digital say they are launching a KODAKOne image rights management platform and a cryptocurrency called KODAKCoin to help empower photographers and       agencies to take greater control in image rights management.</li>     <li>Kodak says the new system will utilize blockchain technology to create an encrypted, digital ledger of rights ownership for       photographers.</li><li>It's a big step from its roots for Eastman Kodak, which was a Dow Jones constituent from 1930 to 2004.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17042483-kodak-wenn-digital-partner-launch-major-blockchain-initiative-cryptocurrency\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321923\" data-linked=\"Old school Kodak +67% on blockchain move\" data-tweet=\"$KODK - Old school Kodak +67% on blockchain move https://seekingalpha.com/news/3321923-old-school-kodakplus-67-on-blockchain-move?source=tweet\" data-url=\"https://seekingalpha.com/news/3321923-old-school-kodakplus-67-on-blockchain-move\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:21 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>56&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321908\" data-ts=\"1515517324\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARDM\" target=\"_blank\">ARDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321908-aradigm-plummets-37-ahead-of-ad-com-review-of-linhaliq\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aradigm plummets 37% ahead of Ad Com review of Linhaliq</a></h4><ul><li>Aradigm (<a href='https://seekingalpha.com/symbol/ARDM' title='Aradigm Corp.'>OTC:ARDM</a> <font color='red'>-36.5%</font>)&nbsp;is getting roughed up after briefing docs were released ahead of Thursday's advisory committee review on inhaled ciprofloxacin for non-cystic fibrosis bronchiectasis, an Orphan Drug, Fast Track and Qualified Infectious Disease indication.</li><li>Investors are clearly signaling that they do not expect a positive vote. In the FDA briefing doc, the results from the two pivotal studies, ORBIT-3 and ORBIT-4 are reviewed.</li><li>ORBIT-3 failed to demonstrate a treatment effect for Cipro while ORBIT-4 did. The FDA reviewers note that the reasons for the different outcomes cannot be determined based on the information collected in the two studies which prevents excluding bias in the results. The reviewers also question (page 32) the validity of the \"time to first exacerbation\" endpoint (over a year compared to placebo) since it is \"unclear\" that it translates into a \"clinically meaningful benefit.\" They also question the duration of the studies saying they may not have been long enough to demonstrate whether Cipro reduced the frequency of exacerbations to a clinically meaningful extent and if the effect is durable beyond a year considering the potential increase in safety signals and bacterial resistance from long-term exposure.</li><li>The FDA's action date for the application is January 26.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321855-aradigm-8-percent-premarket-ahead-ad-com-review-inhaled-ciprofloxacin-chronic-non-cf-lung\" target=\"_blank\">Aradigm down 8% premarket ahead of Ad Com review of inhaled ciprofloxacin for chronic non-CF lung infection</a> (Jan. 9)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3227900-aradigms-ciprofloxacin-shows-mixed-results-two-late-stage-studies-shares-60-percent-premarket\" target=\"_blank\">Aradigm's ciprofloxacin shows mixed results in two late-stage studies; shares down 60% premarket</a> (Dec. 1, 2016)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321908\" data-linked=\"Aradigm plummets 37% ahead of Ad Com review of Linhaliq\" data-tweet=\"$ARDM - Aradigm plummets 37% ahead of Ad Com review of Linhaliq https://seekingalpha.com/news/3321908-aradigm-plummets-37-ahead-of-ad-com-review-of-linhaliq?source=tweet\" data-url=\"https://seekingalpha.com/news/3321908-aradigm-plummets-37-ahead-of-ad-com-review-of-linhaliq\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:02 PM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>8&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321919\" data-ts=\"1515517277\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321919-consumer-top-gainers-losers-of-12-00-pm\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Consumer - Top Gainers / Losers as of 12:00 pm</a></h4><ul>     <li><b>Gainers:</b> ONP <font color='green'>+8%</font>. <a href='https://seekingalpha.com/symbol/SUP' title='Superior Industries International Inc.'>SUP</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/NBEV' title='New Age Beverages Corporation'>NBEV</a> <font color='green'>+6%</font>. <a href='https://seekingalpha.com/symbol/KBSF' title='KBS Fashion Group Limited'>KBSF</a> <font color='green'>+6%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ELF' title='e.l.f. Beauty'>ELF</a> <font color='red'>-14%</font>. <a href='https://seekingalpha.com/symbol/OTIV' title='On Track Innovations Ltd'>OTIV</a> <font color='red'>-7%</font>. <a href='https://seekingalpha.com/symbol/SPWH' title='Sportsman&#39;s Warehouse Holdings, Inc.'>SPWH</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/VUZI' title='Vuzix Corp'>VUZI</a> <font color='red'>-6%</font>. <a href='https://seekingalpha.com/symbol/WKHS' title='Workhorse Group Inc.'>WKHS</a> <font color='red'>-5%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321919\" data-linked=\"Consumer - Top Gainers / Losers as of 12:00 pm\" data-tweet=\"$ITP $SUP $NBEV - Consumer - Top Gainers / Losers as of 12:00 pm https://seekingalpha.com/news/3321919-consumer-top-gainers-losers-of-12-00-pm?source=tweet\" data-url=\"https://seekingalpha.com/news/3321919-consumer-top-gainers-losers-of-12-00-pm\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 12:01 PM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321916\" data-ts=\"1515516282\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/XSPA\" target=\"_blank\">XSPA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321916-xpresspa-opens-off-airport-prototype-location-in-wtc-area\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">XpresSpa opens off-airport prototype location in WTC area</a></h4><ul>   <li>XpresSpa (<a href=\"http://seekingalpha.com/symbol/XSPA\" target=\"_blank\">XSPA</a> <font color='red'>-9.9%</font>) -- <a href=\"https://seekingalpha.com/news/3321500-form-holdings-becoming-xpresspa-group-changing-symbol\" target=\"_blank\">newly named from its old FORM Holdings</a> -- is opening its latest location as an <a href=\"https://seekingalpha.com/pr/17041818-xpresspa-opens-airport-prototype-location-westfield-world-trade-center\" target=\"_blank\">off-airport prototype</a>.</li>    <li>The new spa is located at the Westfield World Trade Center in downtown New York's \"Oculus\" complex.</li>    <li>That spa is located in Manhattan's biggest mall and at its third-largest transport hub, seeing 300,000 daily commuters along with 15M annual global travelers.</li>    <li>The prototype provides the company a valuable look at \"potential to materially expand our addressable market\" beyond airport locations, says President Ed Jankowski.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321916\" data-linked=\"XpresSpa opens off-airport prototype location in WTC area\" data-tweet=\"$XSPA - XpresSpa opens off-airport prototype location in WTC area https://seekingalpha.com/news/3321916-xpresspa-opens-off-airport-prototype-location-in-wtc-area?source=tweet\" data-url=\"https://seekingalpha.com/news/3321916-xpresspa-opens-off-airport-prototype-location-in-wtc-area\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:44 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321913\" data-ts=\"1515516066\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BRPHF\" target=\"_blank\">BRPHF</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321913-novogratzs-crypto-plan-comes-focus\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Novogratz&#39;s crypto plan comes into focus</a></h4><ul><li><a href=\"https://www.bloomberg.com/news/articles/2018-01-09/novogratz-starts-merchant-bank-envisioning-goldman-of-crypto\" target=\"_blank\">via Erik Schatzker at Bloomberg</a></li><li>The former Goldman partner wants to build the Goldman Sachs of crypto, according to a source. In a filing today, he's laid out a series of steps to raise $200M and take his Galaxy vehicle public on Canada's TSX Venture Exchange.</li><li>The crypto merchant bank will be involved with trading, principal investing, asset management, and advisory work.</li><li>Step one will be the purchase of Canadian crypto startup First Coin Capital. Next will be a reverse takeover of Canadian shell Bradmer Pharmaceuticals (<a href='https://seekingalpha.com/symbol/BRPHF' title='Bradmer Pharmaceuticals Inc.'>OTC:BRPHF</a>). That entity would then look to raise C$250M ($201M) in a private placement next month, and be renamed Galaxy Digital Holdings.</li><li>Novogratz plans to put nearly all of his crypto investments into Galaxy - roughly $400M of Bitcoin, Ether, and ICO stakes, as well as positions in blockchain-related startups.</li><li>Related tickers: <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a>, <a href='https://seekingalpha.com/symbol/COIN' title='Winklevoss Bitcoin Trust ETF'>COIN</a>, <a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>, <a href='https://seekingalpha.com/symbol/OSTK' title='Overstock.com, Inc.'>OSTK</a>, <a href='https://seekingalpha.com/symbol/SSC-OLD' title='Seven Stars Cloud Group, Inc.'>SSC-OLD</a>, <a href='https://seekingalpha.com/symbol/MARA' title='Marathon Patent Group, Inc.'>MARA</a>, <a href='https://seekingalpha.com/symbol/UEPS' title='Net 1 UEPS Technologies, Inc.'>UEPS</a>, <a href='https://seekingalpha.com/symbol/BITCF' title='First Bitcoin Capital Corp.'>OTC:BITCF</a>, <a href='https://seekingalpha.com/symbol/XNET' title='Xunlei Limited'>XNET</a>, <a href='https://seekingalpha.com/symbol/GROW' title='U.S. Global Investors, Inc.'>GROW</a>, <a href='https://seekingalpha.com/symbol/BTSC' title='Bitcoin Services, Inc.'>OTCPK:BTSC</a>, <a href='https://seekingalpha.com/symbol/BTCS' title='BTCS Inc.'>OTCQB:BTCS</a>, <a href='https://seekingalpha.com/symbol/MGTI' title='MGT Capital Investments, Inc.'>OTCQB:MGTI</a>, <a href='https://seekingalpha.com/symbol/BTLLF' title='Interbit Ltd.'>OTCPK:BTLLF</a> <a href='https://seekingalpha.com/symbol/SRAX' title='Social Reality Inc.'>SRAX</a>, <a href='https://seekingalpha.com/symbol/GAHC' title='Global Arena Holding, Inc.'>OTCPK:GAHC</a>, <a href='https://seekingalpha.com/symbol/UBIA' title='UBI BlockChain Internet Ltd.'>OTC:UBIA</a>, <a href='https://seekingalpha.com/symbol/ARSC' title='American Security Resources Corp.'>OTC:ARSC</a>, <a href='https://seekingalpha.com/symbol/USTC' title='USA Real Estate Holding Co'>OTCPK:USTC</a>, PRELF, <a href='https://seekingalpha.com/symbol/BLKCF' title='Global Blockchain Technologies Corp.'>OTCPK:BLKCF</a>, <a href='https://seekingalpha.com/symbol/CRCW' title='The Crypto Company'>OTC:CRCW</a>, <a href='https://seekingalpha.com/symbol/COINB' title='Coinbase'>COINB</a>, <a href='https://seekingalpha.com/symbol/LFIN' title='LongFin Corp.A'>OTCPK:LFIN</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321913\" data-linked=\"Novogratz&#39;s crypto plan comes into focus\" data-tweet=\"$BRPHF $BRPHF $GBTC - Novogratz&#39;s crypto plan comes into focus https://seekingalpha.com/news/3321913-novogratzs-crypto-plan-comes-focus?source=tweet\" data-url=\"https://seekingalpha.com/news/3321913-novogratzs-crypto-plan-comes-focus\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:41 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>29&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321912\" data-ts=\"1515515406\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AYI\" target=\"_blank\">AYI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321912-post-earnings-slide-for-acuity-brands\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Post-earnings slide for Acuity Brands</a></h4><ul><li>Acuity Brands (<a href='https://seekingalpha.com/symbol/AYI' title='Acuity Brands, Inc. &#40;Holding Company&#41;'>AYI</a> <font color='red'>-12.1%</font>) is sharply lower after missing FQ1 estimates by a wide margin (sales $843M vs. $873M expected, EPS $1.94 vs. $2.09 expected) with its preliminary report.</li><li>Adjusted operating margin was 15.9% of sales vs. 16.8% a year ago.</li><li>Shares are down to a three-week low.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321849-acuity-brands-misses-0_16-misses-revenue\" target=\"_blank\">Acuity Brands misses by $0.16, misses on revenue</a> (Jan. 9)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321912\" data-linked=\"Post-earnings slide for Acuity Brands\" data-tweet=\"$AYI - Post-earnings slide for Acuity Brands https://seekingalpha.com/news/3321912-post-earnings-slide-for-acuity-brands?source=tweet\" data-url=\"https://seekingalpha.com/news/3321912-post-earnings-slide-for-acuity-brands\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:30 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321911\" data-ts=\"1515515362\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FTNT\" target=\"_blank\">FTNT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321911-fortinetminus-1_6-on-analyst-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Fortinet -1.6% on analyst downgrade</a></h4><ul><li>        Barclays <a href=\"https://www.benzinga.com/analyst-ratings/analyst-color/18/01/11006960/barclays-goes-neutral-on-fortinet-in-tougher-firewall-m\" target=\"_blank\">downgrades</a> Fortinet (NASDAQ:<a href='https://seekingalpha.com/symbol/FTNT' title='Fortinet, Inc.'>FTNT</a>) from Overweight to Equal Weight.</li><li>               Analyst Saket Kalia cites tougher firewall market competition and an industry-wide deceleration that&rsquo;s taking revenue growth to the mid-single digits.&nbsp;</li><li>               Kalia notes peers like Palo Alto have a better advantage due to market share improvement, a refresh cycle, and optionality.&nbsp;</li><li>               The analyst does clarify that Fortinet &ldquo;is not an expensive stock&rdquo; and that the firm &ldquo;can be wrong if more consistent results lead to multiple re-rating.&rdquo;&nbsp;</li><li>               Fortinet shares are&nbsp;<font color='red'>down 1.6%</font>. &nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3321911\" data-linked=\"Fortinet -1.6% on analyst downgrade\" data-tweet=\"$FTNT - Fortinet -1.6% on analyst downgrade https://seekingalpha.com/news/3321911-fortinetminus-1_6-on-analyst-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3321911-fortinetminus-1_6-on-analyst-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:29 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321903\" data-ts=\"1515514023\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MTBC\" target=\"_blank\">MTBC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321903-mtbc-up-5-on-2017-results\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MTBC up 5% on 2017 results</a></h4><ul><li>Nano cap Medical Transcription Billing (<a href='https://seekingalpha.com/symbol/MTBC' title='Medical Transcription Billing'>MTBC</a> <font color='green'>+4.7%</font>) is up on modestly higher volume on the heels of the release of preliminary&nbsp;<a href=\"https://www.sec.gov/Archives/edgar/data/1582982/000149315218000340/ex99-1.htm\" target=\"_blank\">2017 results</a>. Highlights:</li><li>Full-year revenue was ~$31.8M (+30%). Non-GAAP EBITDA was ~$2M compared to loss of ($0.6M) a year ago. Cash balance at year-end was ~$4.4M.</li><li>Final results will be announced in early March. Management will host an earnings call on Wednesday, March 7, at 8:30 am ET.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321903\" data-linked=\"MTBC up 5% on 2017 results\" data-tweet=\"$MTBC - MTBC up 5% on 2017 results https://seekingalpha.com/news/3321903-mtbc-up-5-on-2017-results?source=tweet\" data-url=\"https://seekingalpha.com/news/3321903-mtbc-up-5-on-2017-results\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:07 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321875\" data-ts=\"1515513715\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321875-healthcare-top-5-gainers-losers-of-11-00\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Healthcare - Top 5 Gainers / Losers as of 11:00 am</a></h4><ul>     <li><b>Gainers:</b> <a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+126%</font>. <a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a> <font color='green'>+38%</font>. <a href='https://seekingalpha.com/symbol/CANF' title='Can-Fite Biopharma Ltd'>CANF</a> <font color='green'>+19%</font>. <a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color='green'>+18%</font>. <a href='https://seekingalpha.com/symbol/ABAX' title='ABAXIS, Inc.'>ABAX</a> <font color='green'>+16%</font>.</li><li><b>Losers:</b> <a href='https://seekingalpha.com/symbol/ARDM' title='Aradigm Corp.'>OTC:ARDM</a> <font color='red'>-43%</font>. <a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a> <font color='red'>-36%</font>. <a href='https://seekingalpha.com/symbol/QTNT' title='Quotient Limited'>QTNT</a> <font color='red'>-15%</font>. <a href='https://seekingalpha.com/symbol/APHB' title='AmpliPhi Biosciences Corp.'>APHB</a> <font color='red'>-11%</font>. <a href='https://seekingalpha.com/symbol/BLPH' title='Bellerophon Therapeutics'>BLPH</a> <font color='red'>-10%</font>.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321875\" data-linked=\"Healthcare - Top 5 Gainers / Losers as of 11:00 am\" data-tweet=\"$SAVA $DFFN $CANF - Healthcare - Top 5 Gainers / Losers as of 11:00 am https://seekingalpha.com/news/3321875-healthcare-top-5-gainers-losers-of-11-00?source=tweet\" data-url=\"https://seekingalpha.com/news/3321875-healthcare-top-5-gainers-losers-of-11-00\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 11:01 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321896\" data-ts=\"1515513428\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBT\" target=\"_blank\">GBT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321896-global-bloods-voxelotor-breakthrough-therapy-for-sickle-cell-disease-shares-ahead-19\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Global Blood&#39;s voxelotor a Breakthrough Therapy for sickle cell disease; shares ahead 19%</a></h4><ul><li>The FDA <a href=\"https://seekingalpha.com/pr/17041684-gbt-receives-fda-breakthrough-therapy-designation-voxelotor-treatment-sickle-cell-disease-scd\" target=\"_blank\">designates </a>Global Blood Therapeutics' (<a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color='green'>+19.2%</font>) lead candidate voxelotor a Breakthrough Therapy for the treatment of sickle cell disease. It also has PRIME status in Europe.</li><li>Breakthrough Therapy status provides for more intensive guidance from the FDA on development, the involvement of more senior agency personnel and a rolling review of the marketing application.</li><li><a href=\"http://www.globalbloodtx.com/pipeline/sickle-cell-disease/\" target=\"_blank\">Voxelotor&nbsp;</a>is an oral once-daily therapy that works by increasing hemoglobin's affinity for oxygen.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3311436-global-bloods-late-stage-study-scd-candidate-voxelotor-continue-planned-enrollment-expanded\" target=\"_blank\">Global Blood's late-stage study of SCD candidate voxelotor to continue as planned, enrollment expanded to adolescents; shares ahead 2% premarket</a> (Nov. 13, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321896\" data-linked=\"Global Blood&#39;s voxelotor a Breakthrough Therapy for sickle cell disease; shares ahead 19%\" data-tweet=\"$GBT - Global Blood&#39;s voxelotor a Breakthrough Therapy for sickle cell disease; shares ahead 19% https://seekingalpha.com/news/3321896-global-bloods-voxelotor-breakthrough-therapy-for-sickle-cell-disease-shares-ahead-19?source=tweet\" data-url=\"https://seekingalpha.com/news/3321896-global-bloods-voxelotor-breakthrough-therapy-for-sickle-cell-disease-shares-ahead-19\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321897\" data-ts=\"1515513392\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/JACK\" target=\"_blank\">JACK</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321897-jack-in-box-issues-guidance-icr\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Jack in the Box issues guidance at ICR</a></h4><ul>     <li>Jack in the Box (<a href='https://seekingalpha.com/symbol/JACK' title='Jack In The Box Inc.'>JACK</a> <font color='green'>+1.2%</font>) expects same-store sales to increase 1% to 2% this year, according to the company's ICR presentation.</li>     <li>The restaurant operator also guides for FY18 EBITDA of $260M to $270M and an EBITDA margin rate of +30%.</li>          <li>Share&nbsp; buybacks of ~$200M are expected in the back half of the year.</li>     <li><a href=\"http://investors.jackinthebox.com/presentations\" target=\"_blank\">Jack in the Box ICR presentation webcast</a></li><li><a href=\"https://seekingalpha.com/news/search?query=%23ICR18\" target=\"_blank\">#ICR18</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3321897\" data-linked=\"Jack in the Box issues guidance at ICR\" data-tweet=\"$JACK - Jack in the Box issues guidance at ICR https://seekingalpha.com/news/3321897-jack-in-box-issues-guidance-icr?source=tweet\" data-url=\"https://seekingalpha.com/news/3321897-jack-in-box-issues-guidance-icr\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321893\" data-ts=\"1515512665\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/DFFN\" target=\"_blank\">DFFN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321893-diffusion-pharma-up-39-after-biotech-showcase-presentation\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Diffusion Pharma up 39% after Biotech Showcase presentation</a></h4><ul><li>Thinly traded nano cap Diffusion Pharmaceuticals (<a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a> <font color='green'>+38.8%</font>) is up on a healthy 32x surge in volume. After the close yesterday, CEO David Kalergis delivered a corporate <a href=\"https://seekingalpha.com/pr/17036610-diffusion-pharmaceuticals-present-10th-annual-biotech-showcase-conference\" target=\"_blank\">overview </a>at the 10th Annual Biotech Showcase in San Francisco that clearly pleased investors.</li><li>The company has yet to post the presentation on its website, but a key recent event was the start of a Phase 3 clinical trial assessing lead candidate trans sodium crocetinate &#40;TSC&#41; in newly diagnosed patients with inoperable glioblastoma multiforme, the most common and aggressive form of brain tumor.</li><li>Orphan Drug-tagged TSC is a small molecule that modifies the tumor microenvironment which improves the effectiveness of radiation therapy and chemotherapy.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3301481-fda-signs-phase-3-protocol-diffusion-pharmas-lead-candidate-tsc-shares-ahead-75-percent\" target=\"_blank\">FDA signs off on Phase 3 protocol for Diffusion Pharma's lead candidate TSC; shares ahead 75% premarket</a> (Oct. 17, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321893\" data-linked=\"Diffusion Pharma up 39% after Biotech Showcase presentation\" data-tweet=\"$DFFN - Diffusion Pharma up 39% after Biotech Showcase presentation https://seekingalpha.com/news/3321893-diffusion-pharma-up-39-after-biotech-showcase-presentation?source=tweet\" data-url=\"https://seekingalpha.com/news/3321893-diffusion-pharma-up-39-after-biotech-showcase-presentation\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321889\" data-ts=\"1515512072\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AEO\" target=\"_blank\">AEO</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321889-mall-sector-jittery-icr-rolls-on\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Mall sector jittery as ICR rolls on</a></h4><ul> <li>Retail chains American Eagle Outfitters (<a href='https://seekingalpha.com/symbol/AEO' title='American Eagle Outfitters, Inc.'>AEO</a> <font color='red'>-4.3%</font>), Urban Outfitters (<a href='https://seekingalpha.com/symbol/URBN' title='Urban Outfitters, Inc.'>URBN</a> <font color='red'>-5.8%</font>) and Express (<a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a> <font color='red'>-13.6%</font>) all trade lower after missing sales expectations for the two-month holiday period.</li> <li>AEO and Urban posted positive comparable sales growth, but Express expects to report a negative comp.</li> <li>Investors have their eyes glued to the sector today with the ICR Conference running at full tilt (<a href=\"https://seekingalpha.com/news/search?query=%23ICR18\" target=\"_blank\">see updates</a>). Trading weak on the day are New York &amp; Company (NWY <font color='red'>-8.7%</font>), Citi Trends (<a href='https://seekingalpha.com/symbol/CTRN' title='Citi Trends, Inc.'>CTRN</a> <font color='red'>-6.1%</font>), Abercrombie &amp; Fitch (<a href='https://seekingalpha.com/symbol/ANF' title='Abercrombie & Fitch'>ANF</a> <font color='red'>-4.2%</font>), L Brands (<a href='https://seekingalpha.com/symbol/LB' title='L Brands, Inc.'>LB</a> <font color='red'>-2.7%</font>), Gap (<a href='https://seekingalpha.com/symbol/GPS' title='The Gap, Inc.'>GPS</a> <font color='red'>-1.6%</font>), Chico's FAS (<a href='https://seekingalpha.com/symbol/CHS' title='Chico&#39;s FAS, Inc.'>CHS</a> <font color='red'>-3.3%</font>), Guess (<a href='https://seekingalpha.com/symbol/GES' title='Guess? Inc.'>GES</a> <font color='red'>-2.2%</font>) and Buckle (<a href='https://seekingalpha.com/symbol/BKE' title='The Buckle, Inc.'>BKE</a> <font color='red'>-4.6%</font>).</li><li>#ICR18</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321889\" data-linked=\"Mall sector jittery as ICR rolls on\" data-tweet=\"$AEO $AEO $URBN - Mall sector jittery as ICR rolls on https://seekingalpha.com/news/3321889-mall-sector-jittery-icr-rolls-on?source=tweet\" data-url=\"https://seekingalpha.com/news/3321889-mall-sector-jittery-icr-rolls-on\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:34 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>5&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321880\" data-ts=\"1515511584\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ILMN\" target=\"_blank\">ILMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321880-illumina-expects-strong-finish-for-2017-q4-sales-up-25-shares-ahead-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Illumina expects strong finish for 2017 with Q4 sales up 25%; shares ahead 6%</a></h4><ul><li>Illumina (<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a> <font color='green'>+5.8%</font>)&nbsp;is up in early trading on increased volume on the heels of the release of its JPM18 <a href=\"https://www.illumina.com/content/dam/illumina-marketing/documents/company/investor-relations/ILMN-at-JPM-2018-8-January-2018.pdf\" target=\"_blank\">presentation </a>that will be delivered this afternoon at 3:30 pm PT.</li><li>Q4 sales should be ~$775M (+25%) while full-year revenue should be ~$2.75B (+15%).</li><li>Installed based of instruments now exceeds 11,000. ~285 NovaSeq units shipped.</li><li><strong>2018 guidance</strong>: total revenues: ~$3.12B (+13%); EPS: $4.14 - 4.24; non-GAAP EPS: $4.50 - 4.60.</li><li>#JPM18</li></ul><div class=\"tiny-share-widget\" data-id=\"3321880\" data-linked=\"Illumina expects strong finish for 2017 with Q4 sales up 25%; shares ahead 6%\" data-tweet=\"$ILMN - Illumina expects strong finish for 2017 with Q4 sales up 25%; shares ahead 6% https://seekingalpha.com/news/3321880-illumina-expects-strong-finish-for-2017-q4-sales-up-25-shares-ahead-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3321880-illumina-expects-strong-finish-for-2017-q4-sales-up-25-shares-ahead-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:26 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321883\" data-ts=\"1515510916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/STX\" target=\"_blank\">STX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321883-analysts-up-seagate-price-target-on-prelim-q2-crypto-ties\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Analysts up Seagate price target on prelim Q2, crypto ties</a></h4><ul><li>           Analysts increase Seagate Technology (NASDAQ:<a href='https://seekingalpha.com/symbol/STX' title='Seagate Technology'>STX</a>) price targets following yesterday&rsquo;s preliminary Q2 results and reveal of the company&rsquo;s cryptocurrency ties. </li><li>           Loop Capital raises its Seagate price target by $5 to $55 and maintains Buy rating.  </li><li> Analyst Ananda Baruah says Q2 prelim increases confidence the company can eventually top 32% gross margin. Baruah was less decided on how to value Seagate&rsquo;s Ripple stake since coin market cap doesn&rsquo;t equal equity market cap. </li><li>           Cowen raises its Seagate target from $39 to $47 and rates it Market Perform.  </li><li> Analyst Karl Ackerman says the prelim results show the company is executing in HDDs &ldquo;exceptionally well&rdquo; while the recent NAND supply agreement with Toshiba bolsters that side of the business. </li><li> Morgan Stanley raises its Seagate target by $3 to $40 citing expected cloud demand growth in 1H18 and tailwinds from Q2 near-line storage market share gains. </li><li> Source: Bloomberg First Word </li><li> Seagate shares are&nbsp;<font color='green'>up 1.5%</font>.&nbsp; </li><li>Previously: <a href=\"https://seekingalpha.com/news/3321717-analysts-put-seagates-crypto-stake-2-percent-3-percent\" target=\"_blank\">Analysts put Seagate's crypto stake at 2% to 3%</a> (Jan. 8)</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321731-seagate-releases-preliminary-q2-results\" target=\"_blank\">Seagate releases preliminary Q2 results</a> (Jan. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321883\" data-linked=\"Analysts up Seagate price target on prelim Q2, crypto ties\" data-tweet=\"$STX - Analysts up Seagate price target on prelim Q2, crypto ties https://seekingalpha.com/news/3321883-analysts-up-seagate-price-target-on-prelim-q2-crypto-ties?source=tweet\" data-url=\"https://seekingalpha.com/news/3321883-analysts-up-seagate-price-target-on-prelim-q2-crypto-ties\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:15 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321879\" data-ts=\"1515510308\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/FIT\" target=\"_blank\">FIT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321879-bloomberg-fitbit-eyes-making-smartwatch-for-children\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Bloomberg: Fitbit eyes making smartwatch for children</a></h4><ul>   <li>Fitbit (<a href=\"http://seekingalpha.com/symbol/FIT\" target=\"_blank\">FIT</a> <font color='red'>-2%</font>) is looking at developing a <a href=\"https://www.bloomberg.com/news/articles/2018-01-09/fitbit-is-said-to-consider-developing-smartwatch-for-kids\" target=\"_blank\">smartwatch for children</a>, a plan that has seen months of internal discussion, Bloomberg reports.</li>    <li>Such a product would be in line with the company's increasing focus on health, and could leverage its partnership with glucose-monitoring firm Dexcom to measure sugar level in children along with offering location tracking and games.</li>    <li>Gartner estimates 30% of total smartwatch shipments in 2021 will be from devices targeted at children ages 2-13.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321879\" data-linked=\"Bloomberg: Fitbit eyes making smartwatch for children\" data-tweet=\"$FIT - Bloomberg: Fitbit eyes making smartwatch for children https://seekingalpha.com/news/3321879-bloomberg-fitbit-eyes-making-smartwatch-for-children?source=tweet\" data-url=\"https://seekingalpha.com/news/3321879-bloomberg-fitbit-eyes-making-smartwatch-for-children\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>43&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321878\" data-ts=\"1515510289\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AZZ\" target=\"_blank\">AZZ</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321878-azzminus-9-reviewing-accounting-methodology\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">AZZ -9% reviewing accounting methodology</a></h4><ul><li>AZZ Inc. (<a href='https://seekingalpha.com/symbol/AZZ' title='AZZ incorporated'>AZZ</a> <font color='red'>-9%</font>) takes a tumble in early trade after <a href=\"https://seekingalpha.com/pr/17041422-azz-inc-review-accounting-methodology-resulting-delay-issuance-fiscal-year-2018-third-quarter\" target=\"_blank\">announcing</a> a review of its accounting methodology, which will delay the filing of Form 10-Q for Q3.</li><li>The company now expects to report FY2018 EPS of $1.80-$2.30, but reaffirmed its current revenue guidance of $825M-$885M.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321878\" data-linked=\"AZZ -9% reviewing accounting methodology\" data-tweet=\"$AZZ - AZZ -9% reviewing accounting methodology https://seekingalpha.com/news/3321878-azzminus-9-reviewing-accounting-methodology?source=tweet\" data-url=\"https://seekingalpha.com/news/3321878-azzminus-9-reviewing-accounting-methodology\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:04 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321877\" data-ts=\"1515510120\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321877-10-year-yield-carves-out-new-high\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">10-year yield carves out new high</a></h4><ul><li>There's been little in the way of conventional economic news this week, but the one-way stock market will suffice for bond traders. They've taken the yield on the 10-year Treasury up another four basis points to 2.52%.</li><li>That's the highest since mid-March (the yield hit its 2017 peak on March 10 at 2.58%).</li><li><a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>&nbsp;<font color='red'>-1%</font>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>&nbsp;<font color='green'>+2%</font></li><li><a href=\"https://www.cmegroup.com/trading/interest-rates/stir/30-day-federal-fund.html\" target=\"_blank\">Short-term rate futures markets</a>, meanwhile, are pricing in between two and three rate hikes this year.</li><li>ETFs: <a href='https://seekingalpha.com/symbol/TLT' title='iShares 20+ Year Treasury Bond ETF'>TLT</a>, <a href='https://seekingalpha.com/symbol/TBT' title='ProShares UltraShort 20+ Year Treasury ETF'>TBT</a>, <a href='https://seekingalpha.com/symbol/TMV' title='Direxion Daily 20+ Year Treasury Bear 3x Shares ETF'>TMV</a>, <a href='https://seekingalpha.com/symbol/TBF' title='ProShares Short 20+ Year Treasury ETF'>TBF</a>, <a href='https://seekingalpha.com/symbol/EDV' title='Vanguard Extended Duration Treasury ETF'>EDV</a>, <a href='https://seekingalpha.com/symbol/TMF' title='Direxion Daily 30-Year Treasury Bull 3x Shares ETF'>TMF</a>, <a href='https://seekingalpha.com/symbol/TTT' title='ProShares UltraPro Short 20+ Year Treasury ETF'>TTT</a>, <a href='https://seekingalpha.com/symbol/ZROZ' title='PIMCO 25+ Year Zero Coupon U.S. Treasury Index ETF'>ZROZ</a>, <a href='https://seekingalpha.com/symbol/VGLT' title='Vanguard Long-Term Treasury ETF'>VGLT</a>, <a href='https://seekingalpha.com/symbol/TLH' title='iShares 10-20 Year Treasury Bond ETF'>TLH</a>, <a href='https://seekingalpha.com/symbol/UBT' title='ProShares Ultra 20+ Year Treasury ETF'>UBT</a>, <a href='https://seekingalpha.com/symbol/SPTL' title='SPDR Portfolio Long Term Treasury ETF'>SPTL</a>, <a href='https://seekingalpha.com/symbol/DLBS' title='iPath U.S. Treasury Long Bond Bear ETN'>DLBS</a>, <a href='https://seekingalpha.com/symbol/VUSTX' title='Vanguard Long Term Treasury Fund Inv'>VUSTX</a>, <a href='https://seekingalpha.com/symbol/TYBS' title='Direxion Daily 20+ Year Treasury Bear 1x Shares ETF'>TYBS</a>, <a href='https://seekingalpha.com/symbol/DLBL' title='iPath U.S. Treasury Long Bond Bull ETN'>DLBL</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321877\" data-linked=\"10-year yield carves out new high\" data-tweet=\"$TLT $TBT $TMV - 10-year yield carves out new high https://seekingalpha.com/news/3321877-10-year-yield-carves-out-new-high?source=tweet\" data-url=\"https://seekingalpha.com/news/3321877-10-year-yield-carves-out-new-high\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span> 10:02 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>4&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321872\" data-ts=\"1515509413\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/GBTC\" target=\"_blank\">GBTC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321872-grayscale-investment-trust-opening-for-fresh-funds\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Grayscale Investment Trust opening for fresh funds</a></h4><ul><li>Accredited investors <a href=\"https://grayscale.co/investors/\" target=\"_blank\">will be able to invest</a> directly in <a href='https://seekingalpha.com/symbol/GBTC' title='Grayscale Bitcoin Trust &#40;BTC&#41;'>OTCQX:GBTC</a> at its net asset value. The trust has famously traded at well above the value of its holdings for some time.</li><li>Shares&nbsp;<font color='red'>-2.5%</font>&nbsp;today alongside a similar decline in Bitcoin.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321872\" data-linked=\"Grayscale Investment Trust opening for fresh funds\" data-tweet=\"$GBTC $BTC-USD - Grayscale Investment Trust opening for fresh funds https://seekingalpha.com/news/3321872-grayscale-investment-trust-opening-for-fresh-funds?source=tweet\" data-url=\"https://seekingalpha.com/news/3321872-grayscale-investment-trust-opening-for-fresh-funds\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:50 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>38&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321871\" data-ts=\"1515509340\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/SNCR\" target=\"_blank\">SNCR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321871-synchronoss-appoints-new-cmo\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Synchronoss appoints new CMO</a></h4><ul><li>        Synchronoss (NASDAQ:<a href='https://seekingalpha.com/symbol/SNCR' title='Synchronoss Technologies, Inc.'>SNCR</a>) <a href=\"https://seekingalpha.com/pr/17041801-synchronoss-welcomes-mary-clark-chief-marketing-officer-executive-vice-president\" target=\"_blank\">appoints</a> Mary Clark as the new CMO and VP of Product.</li><li>        Clark previously served as Chief Corporate Relations Officer and Chief of Staff at Syniverse.</li><li>               Synchronoss shares are&nbsp;<font color='red'>down 1.4%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3321871\" data-linked=\"Synchronoss appoints new CMO\" data-tweet=\"$SNCR - Synchronoss appoints new CMO https://seekingalpha.com/news/3321871-synchronoss-appoints-new-cmo?source=tweet\" data-url=\"https://seekingalpha.com/news/3321871-synchronoss-appoints-new-cmo\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:49 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>14&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321869\" data-ts=\"1515509139\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAOI\" target=\"_blank\">AAOI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321869-applied-optominus-5-rosenblatt-highlights-china-competition\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Applied Opto -5% as Rosenblatt highlights China competition</a></h4><ul>   <li>Applied Optoelectronics (NASDAQ:<a href='https://seekingalpha.com/symbol/AAOI' title='Applied Optoelectronics, Inc.'>AAOI</a>) is <font color='red'>off 5%</font> fresh out of today's market open after a note from Rosenblatt says two of its largest customers could be moving business to a rival.</li>    <li>Facebook and Amazon may be transferring share to InnoLight (<a href='https://seekingalpha.com/symbol/INLT' title='InnoLight Technology'>INLT</a>), Jun Zhang says in research that points to the Chinese government working to grow its local ecosystem for optical components amid 5G demand. (h/t Bloomberg)</li>    <li>Huawei and ZTE may start using internal client-side modules in 2018, Zhang suggests.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321869\" data-linked=\"Applied Opto -5% as Rosenblatt highlights China competition\" data-tweet=\"$AAOI $AAOI $INLT - Applied Opto -5% as Rosenblatt highlights China competition https://seekingalpha.com/news/3321869-applied-optominus-5-rosenblatt-highlights-china-competition?source=tweet\" data-url=\"https://seekingalpha.com/news/3321869-applied-optominus-5-rosenblatt-highlights-china-competition\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:45 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>78&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321868\" data-ts=\"1515509081\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ELLI\" target=\"_blank\">ELLI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321868-ellie-mae-up-4-after-barclays-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Ellie Mae up 4% after Barclays upgrade</a></h4><ul><li>Analyst Saket Kalia: 1) We think mortgage volume processed by Ellie Mae's (NYSEMKT:<a href='https://seekingalpha.com/symbol/ELLI' title='Ellie Mae, Inc.'>ELLI</a>) platform will accelerate for the next two years, 2) we have more conviction in our 2018-19 revenue estimates on larger Velocify contribution, 3) we think core Ellie EBITDA and Velcofiy EBITDA can blend to $192M in EBITDA in 2019 - higher than current Street estimates.</li><li>Kalia and team upgrade to Overweight. The $114 price target suggests&nbsp;<font color='green'>26% upside</font>&nbsp;from yesterday's close.</li><li>Shares&nbsp;<font color='green'>up 4.1%</font>&nbsp;to $93.34.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321868\" data-linked=\"Ellie Mae up 4% after Barclays upgrade\" data-tweet=\"$ELLI - Ellie Mae up 4% after Barclays upgrade https://seekingalpha.com/news/3321868-ellie-mae-up-4-after-barclays-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3321868-ellie-mae-up-4-after-barclays-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:44 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321867\" data-ts=\"1515508916\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/VNET\" target=\"_blank\">VNET</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321867-21vianetminus-4_3-on-cfo-departure\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">21Vianet -4.3% on CFO departure</a></h4><ul><li>        21Vianet (NASDAQ:<a href='https://seekingalpha.com/symbol/VNET' title='21Vianet Group'>VNET</a>) <a href=\"https://seekingalpha.com/pr/17041690-21vianet-group-inc-announces-change-leadership-team\" target=\"_blank\">announces</a> the resignation of CFO Terry Want effective immediately.</li><li>               Wang is leaving for personal reasons and will remain on as an advisor to help with the transition.&nbsp;</li><li>               Sharon Xiao Liu will step into the CFO role from her current position as VP of Finance.&nbsp;</li><li>               21Vianet shares are&nbsp;<font color='red'>down 4.3%</font>. &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li></ul><div class=\"tiny-share-widget\" data-id=\"3321867\" data-linked=\"21Vianet -4.3% on CFO departure\" data-tweet=\"$VNET - 21Vianet -4.3% on CFO departure https://seekingalpha.com/news/3321867-21vianetminus-4_3-on-cfo-departure?source=tweet\" data-url=\"https://seekingalpha.com/news/3321867-21vianetminus-4_3-on-cfo-departure\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:41 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321865\" data-ts=\"1515508587\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ROKU\" target=\"_blank\">ROKU</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321865-oppenheimer-roku-accounts-number-lags-expectations-sharesminus-3_4\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Oppenheimer: Roku accounts number lags expectations; shares -3.4%</a></h4><ul>   <li>Roku's (NASDAQ:<a href='https://seekingalpha.com/symbol/ROKU' title='Roku Inc.'>ROKU</a>) filing that says the company's active accounts <a href=\"https://seekingalpha.com/news/3321753-roku-says-active-accounts-hit-19m-shares-gain\" target=\"_blank\">passed 19M as of the end of 2017</a> suggests the company's lagging Oppenheimer's expectations for accounts, the firm says.</li>    <li>Company commentary suggests 19.1M-19.4M active accounts vs. Oppenheimer's expectation for 19.647M (47% growth expected, vs. 43-45% actual). Accounts likely spiked in Q3 and slowed in Q4 due to TV activations in Q3, says analyst Jason Helfstein (h/t Bloomberg).</li>    <li>Shares have come out of the open <font color='red'>down 3.4%</font>. Oppenheimer rates Roku at Underperform.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321865\" data-linked=\"Oppenheimer: Roku accounts number lags expectations; shares -3.4%\" data-tweet=\"$ROKU - Oppenheimer: Roku accounts number lags expectations; shares -3.4% https://seekingalpha.com/news/3321865-oppenheimer-roku-accounts-number-lags-expectations-sharesminus-3_4?source=tweet\" data-url=\"https://seekingalpha.com/news/3321865-oppenheimer-roku-accounts-number-lags-expectations-sharesminus-3_4\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:36 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>26&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321863\" data-ts=\"1515508377\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KS\" target=\"_blank\">KS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321863-citi-expects-m-in-packaging-sector\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Citi expects M&amp;A in the packaging sector</a></h4><ul> <li>Citi calls out KapStone Paper and Packaging Corp. (<a href='https://seekingalpha.com/symbol/KS' title='KapStone Paper and Packaging Corporation'>KS</a>) as one of the most likely acquisition targets in the packaging/paper sector.</li> <li>Analyst Anthony Pettinari thinks WestRock (<a href='https://seekingalpha.com/symbol/WRK' title='WestRock Company'>WRK</a> <font color='red'>-0.2%</font>) and Packaging Corp of America (<a href='https://seekingalpha.com/symbol/PKG' title='Packaging Corporation Of America'>PKG</a>) are the most likely bidders.</li> <li>Other investment firms have already predicted that M&amp;A will be a theme in the packaging sector in 2018.</li> <li>Source: Bloomberg</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321863\" data-linked=\"Citi expects M&amp;A in the packaging sector\" data-tweet=\"$KS $KS $WRK - Citi expects M&amp;A in the packaging sector https://seekingalpha.com/news/3321863-citi-expects-m-in-packaging-sector?source=tweet\" data-url=\"https://seekingalpha.com/news/3321863-citi-expects-m-in-packaging-sector\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:32 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321861\" data-ts=\"1515508104\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TMUS\" target=\"_blank\">TMUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321861-t-mobileplus-1_4-preliminary-q4-shows-1_9m-adds-891k-in-postpaid-phones\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">T-Mobile +1.4% as preliminary Q4 shows 1.9M adds, 891K in postpaid phones</a></h4><ul>   <li>T-Mobile (NASDAQ:<a href='https://seekingalpha.com/symbol/TMUS' title='T-Mobile US, Inc.'>TMUS</a>) is <font color='green'>up 1.4%</font> premarket after noting preliminary Q4 highlights where it <a href=\"https://seekingalpha.com/pr/17041547-t-mobile-adds-5-million-customers-fourth-year-row-stock-repurchase-program-strong-start\" target=\"_blank\">added 1.9M total net subscribers</a>.</li>    <li>Some 1.1M of those were branded postpaid net adds, and of that 891,000 branded postpaid phone net adds.</li>    <li>Churn in branded postpaid phones was down 10 basis points to 1.18%.</li>    <li>That also came with 149,000 net adds in branded prepaid.</li>    <li>The full-year 2017 totals come to 5.7M total net adds (more than 5M for the fourth straight year); 3.6M of those in branded postpaid and 2.8M in branded postpaid phone, along with 855,000 branded prepaid net adds.</li>    <li>The company also says it used 30% of its $1.5B repurchase authorization in 2017 to buy back about 7M shares at an average price per share of $63.34 (a total of $444M).</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321861\" data-linked=\"T-Mobile +1.4% as preliminary Q4 shows 1.9M adds, 891K in postpaid phones\" data-tweet=\"$TMUS - T-Mobile +1.4% as preliminary Q4 shows 1.9M adds, 891K in postpaid phones https://seekingalpha.com/news/3321861-t-mobileplus-1_4-preliminary-q4-shows-1_9m-adds-891k-in-postpaid-phones?source=tweet\" data-url=\"https://seekingalpha.com/news/3321861-t-mobileplus-1_4-preliminary-q4-shows-1_9m-adds-891k-in-postpaid-phones\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321860\" data-ts=\"1515507973\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/INFY\" target=\"_blank\">INFY</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321860-infosys-signs-pricing-agreement-irs\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Infosys signs pricing agreement with the IRS</a></h4><ul><li>           Infosys (NASDAQ:<a href='https://seekingalpha.com/symbol/INFY' title='Infosys Limited, Inc.'>INFY</a>) <a href=\"https://in.reuters.com/article/infosys-usa-tax/infosys-signs-agreement-with-u-s-irs-sees-lower-tax-rate-idINKBN1EY1H8?feedType=RSS&amp;feedName=businessNews&amp;utm_source=feedburner&amp;utm_medium=feed&amp;utm_campaign=Feed%3A+reuters%2FINbusinessNews+%28News+%2F+IN+%2F+Business+News%29\" target=\"_blank\">signs an agreement</a> with the U.S. Internal Revenue Service that lowers its effective tax rate by about 100 basis points. </li><li> The pricing agreement began with talks in 2015 and will now reverse about $225M in previously paid tax provisions.&nbsp; The agreement covers from FY11 to FY21 and Infosys expects to pay about $223M over the next few quarters to cover the difference between taxes payable and actual amount paid. </li><li> Infosys will see a consolidated EPS boost of about $0.10 for the December quarter. </li><li> Infosys shares are&nbsp;<font color='green'>up 0.8%</font>&nbsp;premarket.&nbsp; </li></ul><div class=\"tiny-share-widget\" data-id=\"3321860\" data-linked=\"Infosys signs pricing agreement with the IRS\" data-tweet=\"$INFY - Infosys signs pricing agreement with the IRS https://seekingalpha.com/news/3321860-infosys-signs-pricing-agreement-irs?source=tweet\" data-url=\"https://seekingalpha.com/news/3321860-infosys-signs-pricing-agreement-irs\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:26 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321857\" data-ts=\"1515507780\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321857-premarket-gainers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Gainers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/DFFN' title='Diffusion Pharmaceuticals Inc.'>DFFN</a> <font color='green'>+37%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/MMAC' title='MMA Capital Holdings, Inc.'>MMAC</a> <font color='green'>+24%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321850-mma-capital-management-24-percent-selling-management-business\" target=\"_blank\">selling</a> management business.</li>     <li><a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a> <font color='green'>+23%</font>&nbsp;as abuse-deterrent Remoxy <a href=\"https://seekingalpha.com/news/3321852-pain-therapeutics-abuse-deterrent-remoxy-successful-nasal-abuse-potential-study-shares-ahead\" target=\"_blank\">successful </a>in nasal abuse potential study.</li>     <li><a href='https://seekingalpha.com/symbol/GENE' title='GENETIC TECHNOLOGIES LTD'>GENE</a> <font color='green'>+15%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321776-genetic-technologies-regains-nasdaq-listing-compliance\" target=\"_blank\">regaining</a> Nasdaq listing compliance.</li>     <li><a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a> <font color='green'>+14%</font>&nbsp;as FDA <a href=\"https://seekingalpha.com/news/3321808-fda-signs-pluristems-eap-plx-pad-cells-critical-limb-ischemia-shares-20-percent-premarket\" target=\"_blank\">signs off</a> on Pluristem's EAP for PLX-PAD cells in critical limb ischemia.</li>     <li><a href='https://seekingalpha.com/symbol/ATUS' title='Altice USA'>ATUS</a> <font color='green'>+14%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321760-altice-spinning-67-percent-interest-u-s-unit\" target=\"_blank\">spinning</a> off its 67% interest in U.S. unit.</li>     <li>ITUS <font color='green'>+14%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/YTEN' title='Yield10 Bioscience, Inc.'>YTEN</a> <font color='green'>+13%</font>&nbsp;on encouraging <a href=\"https://seekingalpha.com/pr/17041824-yield10-bioscience-reports-encouraging-results-2017-field-tests-novel-yield-trait-gene-c3003\" target=\"_blank\">results</a> from the 2017 Field Tests of its novel yield trait gene C3003 in Camelina and canola.</li>     <li><a href='https://seekingalpha.com/symbol/CAMT' title='Camtek Ltd.'>CAMT</a> <font color='green'>+10%</font>&nbsp;on <a href=\"https://seekingalpha.com/pr/17041408-camtek-receives-orders-17-tools-next-generation-3d-metrology-system\" target=\"_blank\">receiving</a> multiple order.</li>     <li><a href='https://seekingalpha.com/symbol/VTGN' title='VistaGen Therapeutics, Inc.'>VTGN</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/BIVV' title='Bioverativ Inc.'>BIVV</a> <font color='green'>+8%&nbsp;</font>on BIVV009 <a href=\"https://seekingalpha.com/news/3317581-bioverativs-bivv009-shows-positive-effect-early-stage-study-rare-blood-disorder-shares-ahead\" target=\"_blank\">shows</a> positive effect in early-stage study in rare blood disorder.</li>     <li><a href='https://seekingalpha.com/symbol/MDGS' title='Medigus Ltd'>MDGS</a> <font color='green'>+8%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/HMNY' title='Helios and Matheson Analytics, Inc.'>HMNY</a> <font color='green'>+7%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/GBT' title='Global Blood Therapeutics'>GBT</a> <font color='green'>+6% </font>as FDA <a href=\"https://seekingalpha.com/pr/17041684-gbt-receives-fda-breakthrough-therapy-designation-voxelotor-treatment-sickle-cell-disease-scd\" target=\"_blank\">granted</a> Breakthrough Therapy Designation to voxelotor for the treatment of sickle cell disease.</li>     <li><a href='https://seekingalpha.com/symbol/EXAS' title='EXACT Sciences Corporation'>EXAS</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/CCCR-OLD' title='China Commercial Credit'>CCCR-OLD</a> <font color='green'>+6%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/RUBI' title='The Rubicon Project, Inc.'>RUBI</a> <font color='green'>+5%</font>.</li>     <li><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a> <font color='green'>+5%&nbsp;</font>on <a href=\"https://seekingalpha.com/news/3321844-riot-blockchain-sets-green-energy-unit-shares-6-percent\" target=\"_blank\">setting</a> up green energy unit.</li>     <li><a href='https://seekingalpha.com/symbol/DSX' title='Diana Shipping, Inc.'>DSX</a> <font color='green'>+5%</font>.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321857\" data-linked=\"Premarket Gainers as of 9:05 am\" data-tweet=\"$DFFN $MMAC $SAVA - Premarket Gainers as of 9:05 am https://seekingalpha.com/news/3321857-premarket-gainers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3321857-premarket-gainers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:23 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321856\" data-ts=\"1515507725\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ATUS\" target=\"_blank\">ATUS</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321856-shares-in-altice-u-s-unit-zoom-after-spin-off-plan\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Shares in Altice, U.S. unit zoom after spin-off plan</a></h4><ul>   <li>Altice USA (NYSE:<a href='https://seekingalpha.com/symbol/ATUS' title='Altice USA'>ATUS</a>) is <font color='green'>up 13.8%</font> premarket on NYSE after word that Dutch parent Altice (<a href='https://seekingalpha.com/symbol/ATCEY' title='ALTICE S A ADR'>OTCPK:ATCEY</a>) would <a href=\"https://seekingalpha.com/news/3321760-altice-spinning-67-percent-interest-u-s-unit\" target=\"_blank\">spin off its U.S. unit</a> to existing investors in order to prioritize a turnaround in Europe.</li>    <li>Shares of parent Altice are <font color='green'>up 9.7%</font> in Amsterdam; they've been cut about in half over the past year.</li>    <li>The move is designed to simplify what had become a bit of a sprawling operation after the acquisitions of Suddenlink and Cablevision made for Altice USA -- and to shield the U.S. operation from woes in Europe.</li>    <li>A parting $1.5B dividend payment from the U.S. unit will help improve Altice's balance sheet, which is beset by high debt in an environment of low revenue generation.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321856\" data-linked=\"Shares in Altice, U.S. unit zoom after spin-off plan\" data-tweet=\"$ATUS $ATUS $ATCEY - Shares in Altice, U.S. unit zoom after spin-off plan https://seekingalpha.com/news/3321856-shares-in-altice-u-s-unit-zoom-after-spin-off-plan?source=tweet\" data-url=\"https://seekingalpha.com/news/3321856-shares-in-altice-u-s-unit-zoom-after-spin-off-plan\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:22 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>1&nbsp;<span class='comments-number'>Comment</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321855\" data-ts=\"1515507647\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ARDM\" target=\"_blank\">ARDM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321855-aradigm-down-8-premarket-ahead-of-ad-com-review-of-inhaled-ciprofloxacin-for-chronic-non-cf\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Aradigm down 8% premarket ahead of Ad Com review of inhaled ciprofloxacin for chronic non-CF lung infection</a></h4><ul><li>Thinly traded nano cap Aradigm (<a href='https://seekingalpha.com/symbol/ARDM' title='Aradigm Corp.'>OTC:ARDM</a>) slips&nbsp;<font color='red'>8%</font>&nbsp;premarket on light volume. On Thursday, January 11, the FDA's Antimicrobial Drugs Advisory Committee will <a href=\"https://www.fda.gov/AdvisoryCommittees/Calendar/ucm587656.htm\" target=\"_blank\">meet </a>to discuss its New Drug Application seeking approval for ciprofloxacin dispersion for inhalation for the treatment of non-cystic fibrosis &#40;CF&#41; bronchiectasis patients with chronic lung infections due to <em>Pseudomonas aeruginosa</em>.</li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM591746.pdf\" target=\"_blank\">FDA briefing doc</a></li><li><a href=\"https://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/UCM591747.pdf\" target=\"_blank\">Company briefing doc</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321855\" data-linked=\"Aradigm down 8% premarket ahead of Ad Com review of inhaled ciprofloxacin for chronic non-CF lung infection\" data-tweet=\"$ARDM - Aradigm down 8% premarket ahead of Ad Com review of inhaled ciprofloxacin for chronic non-CF lung infection https://seekingalpha.com/news/3321855-aradigm-down-8-premarket-ahead-of-ad-com-review-of-inhaled-ciprofloxacin-for-chronic-non-cf?source=tweet\" data-url=\"https://seekingalpha.com/news/3321855-aradigm-down-8-premarket-ahead-of-ad-com-review-of-inhaled-ciprofloxacin-for-chronic-non-cf\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:20 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321854\" data-ts=\"1515507192\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/LBCC\" target=\"_blank\">LBCC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321854-long-blockchain-cancels-capital-raise-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Long Blockchain cancels capital raise; shares up 6%</a></h4><ul><li>Long Blockchain (<a href='https://seekingalpha.com/symbol/LBCC' title='Long Blockchain Corp.'>OTCPK:LBCC</a>) is not proceeding with a share sale announced last Friday, but is continuing with plans to purchase 1000 crypto mining rigs. Financing that deal is another question, and the company can make no assurances it will be able to do so.</li><li>Shares&nbsp;<font color='green'>+6.2%</font>&nbsp;premarket</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321419-long-blockchain-deal-1k-mining-machines-offering-shares\" target=\"_blank\">Long Blockchain in deal for 1K mining machines, offering shares</a> (Jan. 5)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321854\" data-linked=\"Long Blockchain cancels capital raise; shares up 6%\" data-tweet=\"$LBCC - Long Blockchain cancels capital raise; shares up 6% https://seekingalpha.com/news/3321854-long-blockchain-cancels-capital-raise-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3321854-long-blockchain-cancels-capital-raise-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321853\" data-ts=\"1515507028\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/\" target=\"_blank\"></a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321853-premarket-losers-of-9-05\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Premarket Losers as of 9:05 am</a></h4><ul>     <li><a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a>&nbsp;<font color='red'>-23%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321820-axsomes-axsminus-02-fails-show-treatment-effect-late-stage-regional-pain-syndrome-study\" target=\"_blank\">announcing</a> AXS-02 Independent Data Monitoring Committee has recommended continuation of COAST-1 trial and discontinuation of CREATE-1 trial.</li><li><a href='https://seekingalpha.com/symbol/MYSZ' title='MySize Inc.'>MYSZ</a> <font color='red'>-21%</font>.</li><li><a href='https://seekingalpha.com/symbol/BGFV' title='Big 5 Sporting Goods Corporation'>BGFV</a>&nbsp;<font color='red'>-18%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321756-big-5-sporting-goods-lowers-q4-guidance-shares-minus-17-percent-ah\" target=\"_blank\">lowering</a> Q4 guidance.</li><li><a href='https://seekingalpha.com/symbol/EXPR' title='Express, Inc.'>EXPR</a>&nbsp;<font color='red'>-17%</font>&nbsp;on <a href=\"https://seekingalpha.com/news/3321789-express-updates-guidance-ahead-icr-presentation\" target=\"_blank\">updating</a> guidance.</li><li><a href='https://seekingalpha.com/symbol/URBN' title='Urban Outfitters, Inc.'>URBN</a>&nbsp;<font color='red'>-5%</font>&nbsp;<a href=\"https://seekingalpha.com/news/3321747-urban-outfitters-slumps-holiday-sales-update\" target=\"_blank\">after</a> holiday sales update.</li><li><a href='https://seekingalpha.com/symbol/TNDM' title='Tandem Diabetes Care, Inc.'>TNDM</a> <font color='red'>-5%</font>.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3321853\" data-linked=\"Premarket Losers as of 9:05 am\" data-tweet=\"$AXSM $MYSZ $BGFV - Premarket Losers as of 9:05 am https://seekingalpha.com/news/3321853-premarket-losers-of-9-05?source=tweet\" data-url=\"https://seekingalpha.com/news/3321853-premarket-losers-of-9-05\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:10 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321852\" data-ts=\"1515506900\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PTIE\" target=\"_blank\">PTIE</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321852-pain-therapeutics-abuse-deterrent-remoxy-successful-in-nasal-abuse-potential-study-shares\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Pain Therapeutic&#39;s abuse-deterrent Remoxy successful in nasal abuse potential study; shares ahead 12% premarket</a></h4><ul><li>Thinly traded nano cap Pain Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PTIE' title='Pain Therapeutics'>PTIE</a>) is up&nbsp;<font color='green'>12%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17041720-pain-therapeutics-reports-positive-top-line-results-nasal-abuse-potential-study-remoxy\" target=\"_blank\">announcement </a>of positive results from a nasal abuse potential study assessing REMOXY ER (extended-release oxycodone capsules CII), its abuse-deterrent formulation of the commonly prescribed opioid pain med.</li><li>The results showed that non-dependent recreational opioid users who snorted the drug reported reduced drug liking compared to immediate-release oxycodone. The data also showed that nasal administration of REMOXY ER resulted in lower exposure to oxycodone, lower peak concentrations and longer time to peak drug concentration than comparator drugs.</li><li>The company says it plans to resubmit its U.S. marketing application shortly.</li><li>Previously: <a href=\"https://seekingalpha.com/news/3318919-pain-therapeutics-resubmit-remoxy-nda-next-quarter-shares-3-percent\" target=\"_blank\">Pain Therapeutics to resubmit Remoxy NDA next quarter; shares up 3%</a> (Dec. 18, 2017)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321852\" data-linked=\"Pain Therapeutic&#39;s abuse-deterrent Remoxy successful in nasal abuse potential study; shares ahead 12% premarket\" data-tweet=\"$PTIE $SAVA - Pain Therapeutic&#39;s abuse-deterrent Remoxy successful in nasal abuse potential study; shares ahead 12% premarket https://seekingalpha.com/news/3321852-pain-therapeutics-abuse-deterrent-remoxy-successful-in-nasal-abuse-potential-study-shares?source=tweet\" data-url=\"https://seekingalpha.com/news/3321852-pain-therapeutics-abuse-deterrent-remoxy-successful-in-nasal-abuse-potential-study-shares\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>17&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321850\" data-ts=\"1515506726\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/MMAC\" target=\"_blank\">MMAC</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321850-mma-capital-management-up-24-after-selling-management-business\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MMA Capital Management up 24% after selling management business</a></h4><ul><li>The Hunt Companies will take over management of MMA Capital Management (NASDAQ:<a href='https://seekingalpha.com/symbol/MMAC' title='MMA Capital Holdings, Inc.'>MMAC</a>), paying $57M in the form of a seven-year note and the assumption of certain liabilities.</li><li>Hunt has also agreed to buy 250K shares of MMAC in two equal tranches - the first to be purchased by March 8 for $33 each, and the 2nd by July 8 at $34.</li><li>MMAC&nbsp;<font color='green'>+24%</font>&nbsp;premarket to $30.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17041259-mma-capital-management-announces-sale-asset-management-businesses-57-million-external\" target=\"_blank\">Press Release</a></li></ul><div class=\"tiny-share-widget\" data-id=\"3321850\" data-linked=\"MMA Capital Management up 24% after selling management business\" data-tweet=\"$MMAC - MMA Capital Management up 24% after selling management business https://seekingalpha.com/news/3321850-mma-capital-management-up-24-after-selling-management-business?source=tweet\" data-url=\"https://seekingalpha.com/news/3321850-mma-capital-management-up-24-after-selling-management-business\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  9:05 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321846\" data-ts=\"1515506266\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AMZN\" target=\"_blank\">AMZN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321846-piper-jaffray-sees-12-upside-for-amazon\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Piper Jaffray sees 12% upside for Amazon</a></h4><ul><li>        Piper Jaffray increases its Amazon (NASDAQ:<a href='https://seekingalpha.com/symbol/AMZN' title='Amazon.com, Inc.'>AMZN</a>) price target by $200 to $1,400, a 12% upside to yesterday&rsquo;s close.</li><li>               The firm examined overall holiday retail spending in the United States and says that Amazon&rsquo;s gross merchandise value &ldquo;suggests only low-to-mid single digit penetration for the company.&rdquo;&nbsp;</li><li>               Rating maintained at Overweight.&nbsp;</li><li>               Amazon shares are&nbsp;<font color='green'>up 0.5%</font>&nbsp;premarket.&nbsp;&nbsp;</li><li>Previously: <a href=\"https://seekingalpha.com/news/3321752-amazon-onboard-brings-alexa-cars-without-internet\" target=\"_blank\">Amazon Onboard brings Alexa to cars with or without internet</a> (Jan. 8)</li></ul><div class=\"tiny-share-widget\" data-id=\"3321846\" data-linked=\"Piper Jaffray sees 12% upside for Amazon\" data-tweet=\"$AMZN - Piper Jaffray sees 12% upside for Amazon https://seekingalpha.com/news/3321846-piper-jaffray-sees-12-upside-for-amazon?source=tweet\" data-url=\"https://seekingalpha.com/news/3321846-piper-jaffray-sees-12-upside-for-amazon\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:57 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>32&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321845\" data-ts=\"1515506143\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AAL\" target=\"_blank\">AAL</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321845-american-airlines-rallies-after-two-notch-baml-upgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">American Airlines rallies after two-notch BAML upgrade</a></h4><ul> <li>Bank of America Merrill Lynch issues a positive call on American Airlines (NASDAQ:<a href='https://seekingalpha.com/symbol/AAL' title='American Airlines Group'>AAL</a>) as it factors in U.S. tax reform to the equation.</li> <li>The firm slides up AAL two notches to Buy from Underperform.</li> <li>The new BAML price target on AAL of $64 reps 22% upside potential for shares.</li> <li>American Airlines is up <font color='green'>2.05%</font> in premarket trading to $53.20. The 52-week high is $54.48.</li>   </ul><div class=\"tiny-share-widget\" data-id=\"3321845\" data-linked=\"American Airlines rallies after two-notch BAML upgrade\" data-tweet=\"$AAL - American Airlines rallies after two-notch BAML upgrade https://seekingalpha.com/news/3321845-american-airlines-rallies-after-two-notch-baml-upgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3321845-american-airlines-rallies-after-two-notch-baml-upgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:55 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321844\" data-ts=\"1515506055\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/RIOT\" target=\"_blank\">RIOT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321844-riot-blockchain-sets-up-green-energy-unit-shares-up-6\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Riot Blockchain sets up green energy unit; shares up 6%</a></h4><ul><li>Digital Green Energy will search globally for spots to set up environmentally-friendly cryptocurrency mining operations.</li><li>Source: <a href=\"https://seekingalpha.com/pr/17041809-b-riot-b-blockchain-establishes-digital-green-energy-corp-new-subsidiary\" target=\"_blank\">Press Release</a></li><li><a href='https://seekingalpha.com/symbol/RIOT' title='Riot Blockchain, Inc.'>RIOT</a>&nbsp;<font color='green'>+6.1%</font>&nbsp;premarket</li></ul><div class=\"tiny-share-widget\" data-id=\"3321844\" data-linked=\"Riot Blockchain sets up green energy unit; shares up 6%\" data-tweet=\"$RIOT - Riot Blockchain sets up green energy unit; shares up 6% https://seekingalpha.com/news/3321844-riot-blockchain-sets-up-green-energy-unit-shares-up-6?source=tweet\" data-url=\"https://seekingalpha.com/news/3321844-riot-blockchain-sets-up-green-energy-unit-shares-up-6\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:54 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>15&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321841\" data-ts=\"1515505171\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/IMAX\" target=\"_blank\">IMAX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321841-moviepass-army-up-to-1_5m\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">MoviePass army up to 1.5M</a></h4><ul>     <li>MoviePass announces that it is now over 1.5M subscribers, jumping from 1.0M subs in under 30 days.</li>         <li>\"We believe the data MoviePass collects from these million and a half movie-goers will become an important asset to our partners and the future of the movie industry,\" says Helios &amp; Matheson Analytics CEO Ted Farnsworth.</li>     <li>\"Based on the dramatic increase in the number of MoviePass subscribers over such a short period of time, we believe MoviePass will continue to grow its subscriber base significantly,&rdquo; says MoviePass CEO&nbsp;Mitch Lowe (early Netflix exec).</li> <li>Shares of MoviePass owner Helios and Matheson Analytics are&nbsp;<font color='green'>up 7.44%</font>&nbsp;in premarket action after the update.</li>     <li>The rapid growth of MoviePass is a factor to watch for overall U.S. movie theater traffic trends in 2018, even if the sustainability of the model is highly debated.</li>     <li>Related stocks: <a href='https://seekingalpha.com/symbol/IMAX' title='IMAX Corporation'>IMAX</a>, <a href='https://seekingalpha.com/symbol/AMC' title='AMC Entertainment Holdings, Inc'>AMC</a>, <a href='https://seekingalpha.com/symbol/RGC' title='Regal Entertainment Group'>RGC</a>, <a href='https://seekingalpha.com/symbol/RDI' title='Reading International, Inc.'>RDI</a>, <a href='https://seekingalpha.com/symbol/MCS' title='Marcus Corporation'>MCS</a>, <a href='https://seekingalpha.com/symbol/CNK' title='Cinemark Holdings, Inc'>CNK</a>, <a href='https://seekingalpha.com/symbol/NFLX' title='Netflix, Inc.'>NFLX</a>.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/17041706-moviepass-surpasses-1_5-million-subscribers\" target=\"_blank\">Press Release</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3321841\" data-linked=\"MoviePass army up to 1.5M\" data-tweet=\"$IMAX $IMAX $AMC - MoviePass army up to 1.5M https://seekingalpha.com/news/3321841-moviepass-army-up-to-1_5m?source=tweet\" data-url=\"https://seekingalpha.com/news/3321841-moviepass-army-up-to-1_5m\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:39 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>40&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321836\" data-ts=\"1515504485\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321836-target-rallies-after-strong-profit-outlook\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Target rallies after strong profit outlook</a></h4><ul>     <li>Shares of Target (NYSE:<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a>) break higher as investors eye the boost in full-year profit guidance.</li>     <li>The retailer pushed up its outlook on 2019 EPS to $5.15 to $5.45 vs. $4.36 consensus.</li>     <li>TGT <font color='green'>+3.45%</font> premarket to $69.50 vs. a 52-week trading rangfe of $48.56 to $72.08. The positive outlook from Target could be enough to give a slight upward nudge to Walmart (NYSE:<a href='https://seekingalpha.com/symbol/WMT' title='Walmart Inc.'>WMT</a>) as well. Walmart is <font color='green'>up 0.47%</font> in premarket action.</li>         <li>Previously: <a href=\"https://seekingalpha.com/news/3321799-target-lifts-guidance-strong-holiday-sales\" target=\"_blank\">Target lifts guidance after strong holiday sales</a> (Jan. 9)</li><li><a href=\"https://seekingalpha.com/news/search?query=%23ICR18\" target=\"_blank\">#ICR18</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3321836\" data-linked=\"Target rallies after strong profit outlook\" data-tweet=\"$TGT $TGT $WMT - Target rallies after strong profit outlook https://seekingalpha.com/news/3321836-target-rallies-after-strong-profit-outlook?source=tweet\" data-url=\"https://seekingalpha.com/news/3321836-target-rallies-after-strong-profit-outlook\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:28 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>16&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321826\" data-ts=\"1515503315\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/KKR\" target=\"_blank\">KKR</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321826-kkr-added-to-goldman-conviction-list-up-1_25-premarket\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">KKR added to Goldman conviction list; up 1.25% premarket</a></h4><ul><li>Capital markets names had a big 2017, says analyst Alexander Blostein, but 2018 isn't looking as good thanks to potentially lower stock market returns, diminishing benefits from rising rates, and varying effects of tax reform.</li><li>Blostein is a bigger fan of alternative investment managers, custodial banks, and traditional asset managers this year, with favorites: KKR (NYSE:<a href='https://seekingalpha.com/symbol/KKR' title='KKR'>KKR</a>), Apollo Global (NYSE:<a href='https://seekingalpha.com/symbol/APO' title='Apollo Global Management, LLC'>APO</a>), State Street (NYSE:<a href='https://seekingalpha.com/symbol/STT' title='State Street Corporation'>STT</a>), BlackRock (NYSE:<a href='https://seekingalpha.com/symbol/BLK' title='BlackRock, Inc.'>BLK</a>), T. Rowe Price (NASDAQ:<a href='https://seekingalpha.com/symbol/TROW' title='T. Rowe Price Group, Inc.'>TROW</a>), and ICE (NYSE:<a href='https://seekingalpha.com/symbol/ICE' title='Intercontinental Exchange, Inc.'>ICE</a>). KKR, in fact, makes the Goldman CL, and is<font color='green'> up 1.25%</font>&nbsp;premarket.</li><li>Source: Bloomberg's Felice Maranz</li></ul><div class=\"tiny-share-widget\" data-id=\"3321826\" data-linked=\"KKR added to Goldman conviction list; up 1.25% premarket\" data-tweet=\"$KKR $KKR $APO - KKR added to Goldman conviction list; up 1.25% premarket https://seekingalpha.com/news/3321826-kkr-added-to-goldman-conviction-list-up-1_25-premarket?source=tweet\" data-url=\"https://seekingalpha.com/news/3321826-kkr-added-to-goldman-conviction-list-up-1_25-premarket\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  8:08 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>10&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321820\" data-ts=\"1515502570\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/AXSM\" target=\"_blank\">AXSM</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321820-axsomes-axsminus-02-fails-to-show-treatment-effect-in-late-stage-regional-pain-syndrome-study\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Axsome&#39;s AXS-02 fails to show treatment effect in late-stage regional pain syndrome study; shares down 23% premarket</a></h4><ul><li>Thinly traded micro cap Axsome Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/AXSM' title='Axsome Therapeutics'>AXSM</a>) slumps&nbsp;<font color='red'>23%</font>&nbsp;premarket on light volume on the heels of its <a href=\"https://seekingalpha.com/pr/17041516-axsome-therapeutics-announces-axsminus-02-independent-data-monitoring-committee-recommends\" target=\"_blank\">announcement </a>that the independent data monitoring committee &#40;DMC&#41; has recommended the termination of the Phase 3 CREATE-1 study assessing co-lead candidate AXS-02 in patients with <a href=\"https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets/Complex-Regional-Pain-Syndrome-Fact-Sheet\" target=\"_blank\">complex regional pain syndrome</a> &#40;CRPS&#41;, a chronic pain condition affecting a limb usually after an injury, due to futility (unlikely to demonstrate a treatment benefit).</li><li>CREATE-1 randomized CRPS patients to receive either AXS-02 or placebo once per week for six weeks. The primary endpoint was the change in weekly average daily pain intensity on a 0-10 scale at week 12.</li><li>The DMC recommended the continuation of another Phase 3, COAST-1, assessing AXS-02 in knee osteoarthritis associated with bone marrow lesions.</li><li><a href=\"http://axsome.com/axs-02/about-axs-02/\" target=\"_blank\">AXS-02</a> (disodium zoledronate tetrahydrate) is an orally administered non-opioid pain therapeutic that inhibits bone turnover and localizes to regions of increased turnover (lesions in the bone marrow). It works by inhibiting an enzyme called farnesyl pyrophosphate synthase which, in turn, reduces the activity of bone cells called&nbsp;<a href=\"https://en.wikipedia.org/wiki/Osteoclast\" target=\"_blank\">osteoclasts</a>, cells that break down bone tissue in the critical process of bone regeneration.</li><li>Management will host a conference call momentarily to discuss the data.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321820\" data-linked=\"Axsome&#39;s AXS-02 fails to show treatment effect in late-stage regional pain syndrome study; shares down 23% premarket\" data-tweet=\"$AXSM - Axsome&#39;s AXS-02 fails to show treatment effect in late-stage regional pain syndrome study; shares down 23% premarket https://seekingalpha.com/news/3321820-axsomes-axsminus-02-fails-to-show-treatment-effect-in-late-stage-regional-pain-syndrome-study?source=tweet\" data-url=\"https://seekingalpha.com/news/3321820-axsomes-axsminus-02-fails-to-show-treatment-effect-in-late-stage-regional-pain-syndrome-study\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:56 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>6&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321809\" data-ts=\"1515501464\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/UAA\" target=\"_blank\">UAA</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321809-under-armour-slides-after-susquehanna-downgrade\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Under Armour slides after Susquehanna downgrade</a></h4><ul> <li>Shares of Under Armour (<a href='https://seekingalpha.com/symbol/UAA' title='Under Armour, Inc.'>UAA</a>, <a href='https://seekingalpha.com/symbol/UA' title='Under Armour, Inc. Class C'>UA</a>) swing lower in premarket action after Susquehanna issues a downgrade to Negative from Neutral.</li> <li>The firm points to poor brand distribution and demand issues in North America.</li> <li>Analyst Sam Poser writes that he doesn't see a fundmental recovery for UA&nbsp;anytime soon.</li> <li>Susquehanna's price target on Under Armour is pushed down to $11.</li><li>Sources: CNBC, Bloomberg</li> <li>UAA <font color='red'>-3.00%</font> premarket to $15.50.</li> </ul><div class=\"tiny-share-widget\" data-id=\"3321809\" data-linked=\"Under Armour slides after Susquehanna downgrade\" data-tweet=\"$UAA $UAA $UA - Under Armour slides after Susquehanna downgrade https://seekingalpha.com/news/3321809-under-armour-slides-after-susquehanna-downgrade?source=tweet\" data-url=\"https://seekingalpha.com/news/3321809-under-armour-slides-after-susquehanna-downgrade\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>39&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321808\" data-ts=\"1515501441\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/PSTI\" target=\"_blank\">PSTI</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321808-fda-signs-off-on-pluristems-eap-for-plx-pad-cells-in-critical-limb-ischemia-shares-up-20\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">FDA signs off on Pluristem&#39;s EAP for PLX-PAD cells in critical limb ischemia; shares up 20% premarket</a></h4><ul><li>Thinly traded micro cap Pluristem Therapeutics (NASDAQ:<a href='https://seekingalpha.com/symbol/PSTI' title='Pluristem Therapeutics, Inc.'>PSTI</a>) is up&nbsp;<font color='green'>20%</font>&nbsp;premarket on increased volume in response to its <a href=\"https://seekingalpha.com/pr/17041510-fda-clears-pluristem-s-expanded-access-program-initiate-treatments-critical-limb-ischemia\" target=\"_blank\">announcement </a>that the FDA has cleared its Expanded Access Program &#40;EAP&#41; for the use of its PLX-PAD cell treatment in patients with critical limb ischemia &#40;CLI&#41;.</li><li>EAP allows the use of an investigational therapy outside of clinical trials in situations where patients are unsuitable for inclusion in the studies and their condition is life-threatening with no realistic treatment options. CLI is an advanced stage of peripheral artery disease that frequently requires amputation of the limbs and has high mortality risk.</li><li>PLX-PAD cell therapy utilizes placental cells to secrete therapeutic proteins that trigger the body's own repair mechanisms which allows it to grow blood vessels and deliver oxygenated blood to damaged tissue, thereby accelerating the healing process.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321808\" data-linked=\"FDA signs off on Pluristem&#39;s EAP for PLX-PAD cells in critical limb ischemia; shares up 20% premarket\" data-tweet=\"$PSTI - FDA signs off on Pluristem&#39;s EAP for PLX-PAD cells in critical limb ischemia; shares up 20% premarket https://seekingalpha.com/news/3321808-fda-signs-off-on-pluristems-eap-for-plx-pad-cells-in-critical-limb-ischemia-shares-up-20?source=tweet\" data-url=\"https://seekingalpha.com/news/3321808-fda-signs-off-on-pluristems-eap-for-plx-pad-cells-in-critical-limb-ischemia-shares-up-20\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:37 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321799\" data-ts=\"1515500012\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/TGT\" target=\"_blank\">TGT</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321799-target-lifts-guidance-after-strong-holiday-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Target lifts guidance after strong holiday sales</a></h4><ul>     <li>Target (NYSE:<a href='https://seekingalpha.com/symbol/TGT' title='Target Corporation'>TGT</a>) updates guidance after factoring in holiday sales.</li>     <li>The retailer expects to report comparable sales growth of 3.4% for the two-month period.</li> <li>Comparable sales across all of the&nbsp; core merchandise categories (Home, Apparel, Food &amp; Beverage, Hardlines and Essentials) were positive and accelerated from the third quarter.</li>     <li>Target lifts Q4 and 2017 EPS guidance based on the benefit of stronger-than-expected holiday sales and recently-enacted federal tax reform.</li>     <li>For Q4, comparable sales growth in a range around 3.4% is anticipated. Sales from new and non-mature stores are expected to contribute approximately 70 basis points to Target's Q4 sales growth. Total sales are expected to grow more than 9% during the quarter.</li>          <li>Target now expects Q4&nbsp;$1.30 to $1.40 vs. $1.24 consensus and $1.05 to $1.25 prior view.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/17041450-target-raises-q4-guidance-stronger-expected-holiday-sales\" target=\"_blank\">Press Release</a></li>     <li><a href=\"https://seekingalpha.com/news/search?query=%23ICR18\" target=\"_blank\">#ICR18</a></li> </ul><div class=\"tiny-share-widget\" data-id=\"3321799\" data-linked=\"Target lifts guidance after strong holiday sales\" data-tweet=\"$TGT - Target lifts guidance after strong holiday sales https://seekingalpha.com/news/3321799-target-lifts-guidance-after-strong-holiday-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3321799-target-lifts-guidance-after-strong-holiday-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:13 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>24&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321798\" data-ts=\"1515499958\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BSX\" target=\"_blank\">BSX</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321798-boston-scientific-reports-preliminary-q4-and-fy17-sales\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Boston Scientific reports preliminary Q4 and FY17 sales</a></h4><ul> <li>Boston Scientific (NYSE:<a href='https://seekingalpha.com/symbol/BSX' title='Boston Scientific Corporation'>BSX</a>) <a href=\"https://seekingalpha.com/pr/17041417-boston-scientific-announces-preliminary-unaudited-sales-fourth-quarter-full-year-ended\" target=\"_blank\">announces</a> preliminary sales for Q4 and FY2017.</li><li>Q4 Net Sales of ~$2.41B, up 9.9% over Q42016 on reported basis.</li>                  <li>For FY2017, the Company generated sales of ~$9.05B, up 7.9% over FY2016 on a reported basis.</li><li>Q4 and FY2017 Interventional Cardiology sales of $0.64B and $2.43B, respectively.</li><li>Q4 and FY2017 Peripheral Interventions&nbsp;sales of $0.28B and $1.08B, respectively.</li><li>Q4 and FY2017 Cardiovascular sales of $0.91B and $3.50B, respectively.</li><li>Q4 and FY2017 Cardiac Rhythm Management&nbsp;sales of $0.49B and $1.90B, respectively.</li><li>Q4 and FY2017 Rhythm Management sales of $0.56B and $2.17B, respectively.</li><li>Q4 and FY2017 MedSurg sales of $0.93B and $3.38B, respectively.</li> <li>The Company will report its Q4 results and provide Q1 2018 and FY 2018 guidance on February 1.</li><li>Shares are up&nbsp;<font color='green'>2%</font>&nbsp;premarket on light volume.</li>  </ul><div class=\"tiny-share-widget\" data-id=\"3321798\" data-linked=\"Boston Scientific reports preliminary Q4 and FY17 sales\" data-tweet=\"$BSX - Boston Scientific reports preliminary Q4 and FY17 sales https://seekingalpha.com/news/3321798-boston-scientific-reports-preliminary-q4-and-fy17-sales?source=tweet\" data-url=\"https://seekingalpha.com/news/3321798-boston-scientific-reports-preliminary-q4-and-fy17-sales\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:12 AM </div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321796\" data-ts=\"1515499510\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/BBW\" target=\"_blank\">BBW</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321796-build-bear-workshop-lower-after-guidance-update\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Build-A-Bear Workshop lower after guidance update</a></h4><ul>          <li>Build-A-Bear Workshop (NYSE:<a href='https://seekingalpha.com/symbol/BBW' title='Build-A-Bear Workshop, Inc.'>BBW</a>) updates guidance ahead of its presentation at the ICR Conference.</li>     <li>The company expects to report revenue of $105M to $110M in Q4 off a comparable sales decline of 7.9%.</li>     <li>E-Commerce sales are expected to increase         11.9% during the quarter.</li>     <li>Build-A-Bear anticipates a GAAP retail gross margin of 50.0% vs. 46.0% a year ago.</li>     <li>Looking ahead to 2019, the company expects revenue to be up at a flat to low single-digit rate.</li>     <li>BBW  <font color='red'>-2.15%</font> premarket to  $9.10.</li>     <li>Source: <a href=\"https://seekingalpha.com/pr/17041375-build-bear-workshop-inc-issues-preliminary-sales-pre-tax-earnings-expectations-ahead\" target=\"_blank\">Press Release</a></li>     <li><a href=\"https://seekingalpha.com/news/search?query=%23ICR18\" target=\"_blank\">#ICR18</a></li>      </ul><div class=\"tiny-share-widget\" data-id=\"3321796\" data-linked=\"Build-A-Bear Workshop lower after guidance update\" data-tweet=\"$BBW - Build-A-Bear Workshop lower after guidance update https://seekingalpha.com/news/3321796-build-bear-workshop-lower-after-guidance-update?source=tweet\" data-url=\"https://seekingalpha.com/news/3321796-build-bear-workshop-lower-after-guidance-update\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  7:05 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>3&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li><li class=\"n-box-item sa-box-item\" data-id=\"3321788\" data-ts=\"1515498744\"><div class=\"media media-overflow-fix\"><div class=\"media-left\"><a class=\"box-ticker\" href=\"/symbol/ILMN\" target=\"_blank\">ILMN</a></div><div class=\"media-body\"><h4 class=\"media-heading\"><a href=\"/news/3321788-illumina-to-sell-fishers-ion-ampliseq-technology\" sasource=\"on_the_move_news_fidelity\" target=\"_blank\">Illumina to sell Fisher&#39;s Ion AmpliSeq technology</a></h4><ul><li>Illumina (NASDAQ:<a href='https://seekingalpha.com/symbol/ILMN' title='Illumina, Inc.'>ILMN</a>) inks an <a href=\"https://seekingalpha.com/pr/17041222-thermo-fisher-scientific-illumina-sign-agreement-provide-research-market-broader-access-ion\" target=\"_blank\">agreement </a>with Thermo Fisher Scientific (NYSE:<a href='https://seekingalpha.com/symbol/TMO' title='Thermo Fisher Scientific Inc.'>TMO</a>) enabling it to sell the latter's Ion AmpliSeq technology to researchers conducting studies on its next-generation sequencing &#40;NGS&#41; platforms. The amplicon technology is highly effective in capturing DNA and RNA from minute samples in a range of research areas.</li><li>Illumina will sell the product directly to researchers under the brand name AmpliSeq. Fisher will continue to market AmpliSeq chemistry for both research use and in vitro diagnostic use to Ion Torrent NGS customers and retains the right to make the technology available on other NGS platforms.</li><li>Financial terms are not disclosed.</li><li><strong>Update</strong>: Shares are up<font color='green'> 7%</font>&nbsp;premarket on light volume.</li></ul><div class=\"tiny-share-widget\" data-id=\"3321788\" data-linked=\"Illumina to sell Fisher&#39;s Ion AmpliSeq technology\" data-tweet=\"$ILMN $ILMN $TMO - Illumina to sell Fisher&#39;s Ion AmpliSeq technology https://seekingalpha.com/news/3321788-illumina-to-sell-fishers-ion-ampliseq-technology?source=tweet\" data-url=\"https://seekingalpha.com/news/3321788-illumina-to-sell-fishers-ion-ampliseq-technology\"><div class=\"icon share-btn c-email\" title=\"Email a friend\">&nbsp;</div><div class=\"icon share-btn c-twitter\" title=\"Share on Twitter\">&nbsp;</div><div class=\"icon share-btn c-facebook\" title=\"Share on Facebook\">&nbsp;</div><div class=\"icon share-btn c-linkedin\" title=\"Share on Linkedin\">&nbsp;</div></div><span class=\"mc_gray_separator\">|</span>  6:52 AM <span class='mc_gray_separator'>|</span> <span class='comments-n'><span class='comments-container '>2&nbsp;<span class='comments-number'>Comments</span></span></span></div></div></li>","count":74,"message":null,"success":true,"today":{"start":1577077200,"end":1577163599,"str":"Monday, December 23, 2019"},"yesterday":{"start":1576990800,"end":1577077199}}